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Summary
Summary
During transcription of eukaryotic protein-coding genes, RNA Polymerase (Pol) II associates
transiently with dozens of transcription factors. Diﬀerent Pol II-associated factors are required
for transcription initiation, RNA chain elongation through chromatin, pre-mRNA 5'-capping,
splicing, 3'-RNA processing of the nascent transcript, and transcription termination. Bye1, a
transcription factor found in yeast, has been linked to Pol II and transcription elongation in
genetic studies.
In this work, we showed that Bye1 binds directly to Pol II, and obtained four crystal
structures of diﬀerent Pol II functional complexes bound by Bye1. The structures revealed
that Bye1 contacts Pol II at a similar position as the general transcription factor TFIIS, but
the details of the interaction diﬀer. Also, Bye1 does not change Pol II conformation, in
contrast to other transcription factors directly contacting Pol II. Functional and structural
analysis revealed that basic Pol II mechanisms like nucleotide incorporation, transcription on
chromatin-free templates, and arrest and backtracking are not aﬀected by Bye1.
Furthermore, we could show that Bye1 is recruited to the 5' region of actively transcribed
genes, and that it interacts in general with histone marks of active chromatin, and speciﬁcally
binds to trimethylated K4 on H3. In addition, we identiﬁed two genes involved in transcription
elongation and histone modiﬁcation that functionally interact with Bye1, namely Paf1 and
Tho2. Based on a detailed bioinformatic search, we determined two putative human homo-
logues of Bye1, namely PHF3 and DIDO. Finally, we generated a structural model of Bye1-
bound Pol II approaching a +2 nucelosome by combining data obtained during this and other
studies. The model shows that it is structurally possible for Bye1 to interact simultaneously
with Pol II and histone tails emerging from the +2 nucleosome.
Based on our data, we propose that Bye1 may be the founding member of a new family of
transcription factors that link early transcribing Pol II to histones in yeast and human cells.
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Part I
Introduction
1 Transcription by DNA-dependent RNA Polymerases
1.1 Transcription in eukaryotes
In all living organisms, genetic information is stored in form of DNA, and DNA-dependent
RNA polymerases are required for DNA transcription to synthesize RNA. Although the active
site of diﬀerent RNA polymerases is structurally discrete and evolutionarily unrelated, all RNA
polymerases have a common structural framework and operate by closely related molecular
mechanisms (Werner, 2007).
Whereas archaea and bacteria use a single RNA polymerase to transcribe all genes, eu-
karyotes use several classes of polymerases that transcribe distinct subsets of genes (Werner,
2007). RNA Polymerase (Pol) I, II, and III synthesize the 25S rRNA precursor, messenger RNAs
(mRNAs), and short untranslated RNAs such as transfer RNAs (tRNAs) and 5S ribosomal RNA
(rRNA), respectively. In plants, Pol IV and V additionally transcribe non-coding RNAs required
for RNA interference (Matzke et al., 2009). In addition, separate RNA polymerases, which are
similar to phage RNA polymerases, are found in chloroplasts and mitochondria, where they
speciﬁcally transcribe the DNA of those organelles.
Although the diﬀerent polymerases transcribe distinct subsets of genes, they share several
common features (Table 1, Vannini & Cramer, 2012). Pol I, II and III contain 14, 12, and
17 subunits, respectively, and the two largest subunits are related to those of the bacterial
polymerase. In addition, ﬁve of the core subunits are conserved among Pol I, II and III.
Consistent with these structural similarities, the diﬀerent eukaryotic polymerases share several
functional properties, including the need to interact with other proteins to appropriately initiate
transcription. As functional diﬀerences are required for transcribing distinct subsets of genes,
the core of the enzyme is decorated with additional polymerase-speciﬁc factors.
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Table 1: RNA polymerase subunits in yeast. Adapted from Vannini & Cramer, 2012.
Pol I Pol II Pol III
Polymerase core
A190 Rpb1 C160
A135 Rpb2 C128
AC40 Rpb3 AC40
Rpb5 Rpb5 Rpb5
Rpb6 Rpb6 Rpb6
Rpb8 Rpb8 Rpb8
A12.2 N ribbon Rpb9 C11 N ribbon
Rpb10 Rpb10 Rpb10
AC19 Rpb11 AC19
Rpb12 Rpb12 Rpb12
Polymerase Stalk
A14 Rpb4 C17
A43 Rpb7 C25
General transcription factors and their counterparts
A49 N term Tfg1 (TFIIFα) C37
A34.5 Tfg2 (TFIIF β) C53
Tfa1 (TFIIEα) C82
A49 C term Tfa2 (TFIIEβ) C34
C31
TBP TBP TBP
TAFs
Rrn7 TFIIB Brf1
Speciﬁc factors
B
Rrn6
Rrn11
SAGA
TFIIH
Rrn3 Mediator
UAF
TFIIIC
SNAPc
2
Introduction
1.2 Regulation of RNA polymerase II transcription
1.2.1 The RNA polymerase II transcription cycle
The transcription cycle of Pol II can be divided into four steps (Fig. 1): pre-initiation, ini-
tiation, elongation and termination. Pol II is recruited to the promoter during pre-initiation,
where melting of the DNA and pre-initiation complex formation occurs. During initiation,
incorporation of the ﬁrst nucleotides takes place. This process is marked by physical and func-
tional instability of the transcription complex, and results in formation of abortive transcripts.
However, when nascent RNA reaches a length of 14-15 nucleotides, transition to the elongation
stage of transcription occurs (Dvir, 2002), where processive catalysis generates the bulk of the
RNA. Finally, transcription is terminated when Pol II reaches the 3' end of the transcribed
gene, and Pol II can then be recycled for another round of transcription.
Figure 1: RNA Polymerase II transcription cycle.
In 1980, Robert Roeder and his colleagues discovered that transcription in the eukaryotic
system requires distinct transcription factors during all stages of the transcription cycle (Matsui
et al., 1980). These so-called general transcription factors are involved in transcription from
all Pol II promoters and therefore constitute part of the basic transcription machinery.
1.2.2 General transcription factors in yeast
Five general transcription factors are required for initiation of transcription by Pol II (Table
2, Sikorski & Buratowski, 2009). The ﬁrst step in formation of a transcription complex is
3
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the binding of the general transcription factor TFIID to the TATA box via its TATA-binding
protein (TBP). TBP binding induces a 90° kink in the DNA (Kim et al., 1993a,b), which then
allows binding of a second general transcription factor, TFIIB. TFIIB in turn serves as a bridge
between the TBP-DNA complex and Pol II (Bushnell et al., 2004; Kostrewa et al., 2009; Liu
et al., 2010; Sainsbury et al., 2013), which is recruited to the promoter in association with a
third general transcription factor, TFIIF. Binding of two additional factors, TFIIE and TFIIH,
is required for initiation of transcription. TFIIE enhances recruitment of TFIIH to promoters,
where TFIIH assists in promoter opening and clearance by unwinding DNA and phosphorylating
the C-terminal domain (CTD) of Rpb1, the largest Pol II subunit (Lee & Young, 2000).
Table 2: General transcription factors in yeast. Adapted from Sikorski & Buratowski, 2009
Protein complex Subunits Function
TFIIB 1 stabilizes TFIID-promoter binding; aids in recruitment of
TFIIF/Pol II to the promoter; directs accurate start site selection
TFIID 14 nucleates PIC assembly either through TBP binding to TATA
sequences or TAF binding to other promoter sequences;
coactivator activity through direct interaction of TAFs and gene
speciﬁc activators
TFIIE 2 helps recruit TFIIH to promoters; stimulates helicase and kinase
activities of TFIIH; binds ssDNA and is essential for promoter
melting
TFIIF 3 tightly associates with Pol II; enhances aﬃnity of Pol II for
TBP-TFIIB-promoter complex; necessary for recruitment of
TFIIE/TFIIH to the PIC; aids in start site selection and
promoter escape; enhances elongation eﬃciency
TFIIH 10 ATPase/helicase necessary for promoter opening and promoter
clearance; helicase activity for transcription coupled DNA repair;
kinase activity required for phosphorylation of Pol II CTD;
facilitates transition from initiation to elongation
1.2.3 General transcription factor TFIIS
The above described general transcription factors are required during initiation of transcription.
The general transcription factor TFIIS, however, is required during transcription elongation. In
contrast to other elongation factors that stimulate nucleotide incorporation, TFIIS re-activates
Pol II during arrest and backtracking (Fig. 2, Sigurdsson et al., 2010; Cheung & Cramer,
4
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2011). Pol II arrest and reactivation occur during promoter-proximal gene regulation and
transcription through nucleosomes. Certain DNA sequences cause Pol II to arrest, which is
followed by backtracking, displacement of the RNA to a so-called backtrack site, and inhibition
of elongation (Adelman et al., 2005; Kireeva et al., 2005), due to misalignment of the catalytic
3' OH group of the RNA (Wang et al., 2009; Cheung & Cramer, 2011).
Figure 2: Mechanism of Pol II backtracking, arrest and reactivation. Adapted from Cheung & Cramer, 2011.
TFIIS contains three domains, a mobile N-terminal domain, a central domain that binds
directly to the Pol II jaw and funnel domains, and a C-terminal zinc ribbon domain that
5
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inserts into the polymerase pore and reaches the Pol II active site (Kettenberger et al., 2003).
During backtracking, the C-terminal zinc ribbon domain stimulates cleavage of backtracked
RNA (Wind & Reines, 2000) and thereby re-activates Pol II transcription by restoring the RNA
3' OH in the active site (Wang et al., 2009; Cheung & Cramer, 2011).
2 S.cerevisiae RNA Polymerase II
2.1 Architecture and subunit composition
Pol II consists of a 10-subunit core enzyme and a peripheral Rpb4/7 subcomplex (Table 1),
and comprises 513 kDa.
The ﬁrst crystal structure of the ten subunit Pol II core was solved in 2001 (Cramer et al.,
2001) at 3 Å. The backbone model revealed that Rpb1 and Rpb2 constitute the bulk of the
enzyme and form the active centre, whereas the smaller subunits are distributed around the
periphery (Fig. 3a,b). Crystallographic backbone models of the complete, 12-subunit Pol II,
revealed the position and orientation of the peripheral Rpb4/7 subcomplex in 2003 (Fig. 3c,
and Armache et al., 2003; Bushnell & Kornberg, 2003). A crystal structure of free Rpb4/7 and
improved resolution of the complete Pol II crystals ﬁnally enabled reﬁnement of a complete
atomic model of Pol II (Armache et al., 2005).
In addition to the domains described in the crystal structures, Pol II contains a tail-like
domain, the C-terminal domain (CTD) of Rpb1. The CTD is ﬂexibly linked to the core
enzyme and consists of heptapeptide repeats of the consensus sequence YSPTSPS, which are
diﬀerentially phosphorylated during the transcription cycle (Heidemann et al., 2013). CTD-
binding proteins recognize a speciﬁc CTD phosphorylation pattern and are involved in mRNA
biogenesis (Hsin & Manley, 2012).
Pol II is highly conserved across species, with yeast and human Pol II sequences exhibiting
53% overall identity (Cramer et al., 2001), and ten subunits encoded by human genes can
replace their counterparts in yeast Pol II without loss of cell viability (Woychik, 1998).
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Figure 3: Architecture and subunit composition of S.cerevisiae Pol II.
(A) Ribbon model of 10-subunit Pol II (Cramer et al., 2001). (B) Scheme of 12-subunit Pol II showing localisation of all subunits.
(C) Ribbon model of 12-subunit Pol II (Armache et al., 2003). The views correspond to the top and front views of Pol II (Cramer
et al., 2001).
2.2 Structures of Pol II elongation complexes
The ﬁrst crystal structure of Pol II in complex with nucleic acids revealed the location of
downstream DNA in the cleft, and resolved a 9-base pair DNARNA hybrid duplex emanating
at right angles to the incoming DNA from the active site at the ﬂoor of the cleft (Gnatt et al.,
2001). Subsequent higher-resolution structures of core Pol II (Westover et al., 2004a,b) and
complete Pol II (Kettenberger et al., 2004) with synthetic nucleic acid scaﬀolds provided a
comprehensive view of the elongation complex, including nucleotides upstream of the hybrid
and interactions of nucleic acids with polymerase domains involved in elongation complex
maintenance (Fig. 4, and Martinez-Rucobo & Cramer, 2013).
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Figure 4: Structures of Pol II elongation complexes.
(A) Ribbon model of the Pol II elongation complex with bound NTP (this work). The bridge helix (green), trigger loop (purple),
and metal A (pink) are highlighted. DNA template, DNA non-template, RNA, and NTP are shown in blue, cyan, red, and orange,
respectively. (B) Contacts of the NTP substrate with Pol II residues, DNA template, RNA and metal A.
2.3 Structures of Pol II in complex with transcription factors
Thus far, X-ray crystallographic structural information on the complete Pol II in complex with
additional factors is limited to two transcription factors, the initiation factor TFIIB (Bushnell
et al., 2004; Kostrewa et al., 2009; Liu et al., 2010; Sainsbury et al., 2013), and the elongation
factor TFIIS (Kettenberger et al., 2003, 2004; Wang et al., 2009; Cheung & Cramer, 2011).
Structures of Pol II in complex with TFIIB and nucleic acids revealed how TFIIB assists in
positioning and opening of the DNA, recognition of the initiator sequence and stimulation
of initial RNA, followed by directing RNA to its exit tunnel (Fig. 5A). Structures of Pol II
in complex with TFIIS and nucleic acids revealed how TFIIS contacts the Pol II jaw and
funnel domains via its central domain (domain II), and how the C-terminal zinc ribbon domain
(domain III) inserts into the Pol II pore and reaches the Pol II active site to stimulate cleavage
of backtracked RNA during transcriptional proofreading and escape from arrest (Fig. 5B).
8
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Figure 5: Structures of Pol II-transcription factor complexes.
(A) Ribbon model of the Pol II-nucleic acid-TFIIB complex (Sainsbury et al., 2013). (B) Ribbon model of the Pol II-nucleic
acid-TFIIS complex (Cheung & Cramer, 2011).
3 Transcription factor Bye1
In S.cerevisiae, there is only a single protein that contains a domain that is distantly homologous
to the central, Pol II-associated domain of TFIIS. This protein, Bye1, has been identiﬁed as a
multi-copy suppressor of Ess1 (Wu et al., 2000), a peptidyl-prolyl cis-trans isomerase involved
in proline isomerization of the C-terminal domain (CTD) of Pol II (Morris et al., 1999; Hani
et al., 1995). In Bye1, the central TFIIS-like domain (TLD, residues 232-365) is ﬂanked by an
N-terminal PHD domain (residues 74-134) and a C-terminal SPOC domain (residues 447-547,
Fig.6).
Figure 6: Domain organization of S.cerevisiae Bye1.
PHD: Plant Homeodomain, TLD: TFIIS-like domain, SPOC: Spen paralogue and orthologue C-terminal domain. Bordering residue
numbers are indicated.
PHD domains are mostly found in proteins involved in chromatin-mediated gene regulation
(Aasland et al., 1995). Consistent with this, the Bye1 PHD domain binds to a histone H3
tail peptide containing trimethylated lysine 4 (H3K4me3) (Shi et al., 2007). The function of
SPOC domains in yeast is unclear, but in higher eukaryotes SPOC domains are implicated in
9
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developmental signalling (Ariyoshi & Schwabe, 2003). Bye1 localizes to the nucleus (Kumar
et al., 2000), consistent with harbouring putative nuclear localization signals in the N-terminal
protein region. Based on yeast genetics, it was suggested that Bye1 plays an inhibitory role
during transcription elongation (Wu et al., 2003). It is unknown whether Bye1 binds to Pol II
directly, and what the consequences of such binding are for polymerase structure and function.
4 Chromatin and transcription in yeast
Packaging of eukaryotic DNA in chromatin plays an essential role in the control of transcription.
Chromatin structure has important consequences in terms of availability of DNA as template for
transcription, and changes in transcription are therefore correlated with changes in chromatin
structure. In general, actively transcribed genes are found in decondensed chromatin, where
nucleosome occupancy is reduced and an increased width and depth of nucleosome-free regions
(NFR) can be observed (Jiang & Pugh, 2009; Yen et al., 2012). Nucleosomes represent a major
barrier for Pol II transcription in vivo and in vitro, and additional factors are required to increase
accessibility for the transcription machinery (Clark & Felsenfeld, 1992; Studitsky et al., 1997).
So-called chromatin-modulating factors are recruited by transcription factors or by Pol II, but
it is also known that Pol II passage itself can aﬀect chromatin structure (Kulaeva et al., 2009;
Kulaeva & Studitsky, 2010; Yen et al., 2012).
4.1 Nucleosome architecture
The nucleosome is the basic repeating unit of chromatin. It comprises an octameric assembly
composed of two copies of each of the four canonical histone proteins (H3, H4, H2A, and
H2B), around which 147 bp of DNA are wrapped (Fig.7, Luger et al., 1997). Every 10.4 bp,
histones contact the phosphate backbone of the DNA via positively charged residues. These
histone-DNA contacts are weak by themselves, but provide positional stability when added
together. Histone variant proteins can be incorporated into nucleosomes and provide speciﬁc
functions to distinct regions of chromatin.
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Figure 7: Ribbon (left) and surface (right) model of a core nucleosome (Luger et al., 1997).
4.2 Chromatin remodelling factors
Chromatin-remodelling factors are multi-protein complexes that use the energy of ATP hy-
drolysis to alter nucleosome position, stability, and composition. Eukaryotic cells contain four
families of chromatin-remodelling complexes (Swi/Snf, ISWI, Chd, and Ino80), which share
common mechanisms of disrupting histone-DNA interactions (Clapier & Cairns, 2009). Chro-
matin remodellers often act in concert with transcription factors, and regulate transcription at
diﬀerent stages. For example, Swi/Snf-dependent remodelling has been shown to positively
regulate transcription at 5' regulatory regions and during elongation, whereas ISWI-dependent
remodelling results in repression of transcription by occluding promoter regions (Rando &
Winston, 2012).
4.3 Histone modiﬁcations
In addition to chromatin remodelling, post-translational modiﬁcations (PTMs) of histone tails
play regulatory roles during transcription. The tails of the core histones are unstructured and
protrude outward from the nucleosome core and are subject to a range of reversible PTMs,
including acetylation, methylation, phosphorylation, ubiquitylation and sumoylation (for an
overview of histone modiﬁcations in S.cerevisiae, see Table 3, Smolle & Workman, 2013).
While some histone modiﬁcations can directly inﬂuence chromatin structure, many of them
11
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can be bound and recognized by proteins and protein complexes that act on chromatin. It
is still strongly debated whether single histone modiﬁcations or rather the combination of
diﬀerent histone modiﬁcations determine the downstream eﬀect on cellular processes such as
transcription, replication and DNA repair ('histone code hypothesis', Rando, 2012).
The best studied modiﬁcations are lysine acetylation and methylation. Whereas acetylation
is associated with active transcription, methylation is associated either with active or repressed
chromatin, depending on the context and extent (mono-, di-, trimethylation).
Methylation of H3K4 is exclusively linked to transcriptional activation, and is carried out
by the COMPASS methylase complex (Shilatifard, 2008). It consists of Set1/KMT2 and seven
other polypeptides (named Cps60-Cps15), and mono-, di- and trimethylates H3K4 (Miller
et al., 2001; Roguev et al., 2001). H3K4 methylation is localized near the transcription start
site for actively transcribed genes (Krogan et al., 2003; Ng et al., 2003), and this localization
pattern was also observed in higher eukaryotes (Bernstein et al., 2005).
Several factors directly associating with di- and trimethylated H3K4 have been identiﬁed,
including the CHD1 protein and proteins containing a plant homeodomain (PHD), such as the
TAF3 subunit of the general transcription factor TFIID (Shi et al., 2007; Pray-Grant et al.,
2005). In humans, H3K4me3 has been suggested to be involved in pre-mRNA maturation by
bridging spliceosomal components and CHD1 to actively transcribed genes (Sims et al., 2007).
Table 3: S.cerevisiae core histone modiﬁcations. Adapted from Smolle & Workman, 2013.
ac: acetylation, me: methylation, p: phosphorylation, sumo: sumoylation, ub: ubiquitylation
Histone Residue Modiﬁcation Enzyme Recognized by Function
H2A K4 ac Esa1 Transcription activation
K7 ac Esa1 Transcription activation
K126 sumo Ubc9, Siz1, Siz2 Transcription repression
H2B K6 sumo Ubc9, Siz1, Siz2 Transcription repression
K7 Transcription repression
S10 p Ste20 Apoptosis
K11 ac Gcn5 Transcription activation
K16 ac Gcn5, Esa1 Transcription activation
K16 sumo Ubc9, Siz1, Siz2 Transcription repression
K17 Transcription repression
K123 ub Cps35 Transcription activation
H3 R2 me WD40 Transcription
repression/activation
12
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K4 me Set1 PHD, Chromo,
WD40, ADD,
Tudor, MBT,
Zf-CW
Transcription activation
R8 me WD40 Transcription repression
K9 ac Gcn5, Rtt109 PHD, Chromo,
Tudor, WD40,
Ankyrin
Transcription activation
me Silencing
S10 p Snf1, Ipl1 Gcn5, 14-3-3 Transcription
activation, mitosis,
meiosis
K14 ac Gcn5, Hpa2,
Esa1, Elp3,
Sas2, Sas3
Bromo, PHD Transcription activation
R17 me Tudor Transcription activation
K18 ac Gcn5 Transcription activation
K23 ac Gcn5, Sas3 Transcription activation
me Chromo
R26 me
K27 ac Gcn5, Rtt109 Transcription activation
me Chromo, WD40 Silencing
K36 ac Gcn5 Transcription activation
me Set2 Chromo, PHD,
PWWP
Transcription
elongation
K56 ac Rtt109 PHD Transcription activation
K79 me Dot1 Tudor
H4 R3 me Rmt1 Tudor, ADD Transcription activation
K5 ac Esa1 Bromo Transcription activation
sumo Ubc9, Siz1, Siz2 Transcription repression
K8 ac Esa1, Elp3, Gcn5 Bromo Transcription activation
sumo Ubc9, Siz1, Siz2 Transcription repression
K12 ac Hat1, Esa1,
Hpa2
Transcription activation
sumo Ubc9, Siz1, Siz2 Transcription repression
K16 ac Sas2, Esa1 Bromo Transcription activation
sumo Ubc9, Siz1, Siz2 Transcription repression
K20 me Tudor, MBT,
PWWP, WD40
Transcription
activation/repression
sumo Ubc9, Siz1, Siz2 Transcription repression
13
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5 Aims and scope
So far, Bye1 has been linked to Pol II in genetic studies, and an association with chromatin
has been proposed. However, it is unknown whether Bye1 binds Pol II directly, and what the
consequences of such binding are for Pol II structure. Furthermore, it is not known if and how
Bye1 aﬀects basic Pol II mechanisms, and whether it inﬂuences Pol II transcription on a global
level, or rather regulates transcription of a speciﬁc subset of genes. In addition, the functions
of the individual domains have not been elucidated, and it is not clear whether they contribute
to Bye1 function cooperatively, or whether they act in a timely sequence.
In order to answer these questions, we aimed to elucidate the structure of the Pol II-Bye1
complex, and thereby describe the eﬀect of Bye1 on Pol II structure and function. Furthermore,
we aimed to elucidate Bye1 function by using genetic, biochemical and biophysical assays as
well as systems biology.
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Part II
Materials and Methods
6 Materials
6.1 Bacterial strains
Table 4: E.coli strains used in this study
Strain Base
strain
Genotype Source
E.coli XL1 Blue K12 rec1A; endA1; gyrA96; thi-1; hsdR17; supE44;
relA1; lac[F' proAB lacI qZDM15 Tn10 (Tetr)]
Stratagene
E.coli BL21 Gold RIL DE3 B; F-; ompT ; hsdS(rB- mB-);dcm+; Tetr;
gal_(DE3); endA; Hte [argU, ileY, leuW,
Camr]
Stratagene
6.2 Yeast strains
Table 5: S.cerevisiae strains used or generated in this study
Strain Genotype Source
WT BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0 Euroscarf
bye1∆ BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YKL005C::KanMX
Euroscarf
paf1∆ BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YBR279W::clonNAT
this work
tho2∆ BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YNL139C::clonNAT
this work
bye1∆paf1∆ BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YKL005C::KanMX; YBR279W::clonNAT
this work
bye1∆tho2∆ BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YKL005C::KanMX; YNL139C::clonNAT
this work
TAP-Bye1 BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YKL005C::YKL005C-TAP-KanMX
Open
Biosystems
bye1∆
(SL-screen)
BY5563; MATalpha; can1D::MFA1pr-HIS3; lyp1D; ura3D0; leu2D0;
YKL005c::ClonNAT
this work
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fyv6∆ BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YNL133C::clonNAT
this work
bye1∆fyv6∆ BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YKL005C::KanMX; YNL133C::clonNAT
this work
pGAL1-3xHA-Bye1 BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YKL005C::KanMX-pGAL1-HA-YKL005c
this work
TAP-Bye1 dst1∆* BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YGL043W::clonNAT; YKL005C::YKL005C-TAP-KanMX
this work
TAP-TFIIS BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YGL043W::KanMX-TAP-YGL043W
Andreas
Mayer
TAP-Dst1 bye1∆ BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YKL005C::clonNAT; YGL043W::KanMX-TAP-YGL043W
this work
dst1∆ BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YGL043W::KanMX
Euroscarf
dst1∆paf1∆ BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YGL043W::clonNAT; YBR279W::KanMX
this work
dst1∆tho2∆ BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YGL043W::KanMX; YNL139C::clonNAT
this work
dst1∆fyv6∆ BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YGL043W::clonNAT; YNL133C::KanMX
this work
TAP-Rpb3 BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YIL021W::YIL021W-TAP-KanMX
Open
Biosystems
TAP-Rpb3 bye1∆ BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YKL005C::clonNAT; YIL021W::YIL021W-TAP-KanMX
this work
TAP-Paf1 BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YBR279W::YBR279W-TAP-KanMX
Open
Biosystems
TAP-Paf1 bye1∆ BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YKL005C::clonNAT;YBR279W::YBR279W-TAP-KanMX
this work
TAP-Tho2 BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YNL139C::YNL139C-TAP-KanMX
Open
Biosystems
TAP-Tho2 bye1∆ BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YKL005C::clonNAT; YNL139C::YNL139C-TAP-KanMX
this work
TAP-Fyv6 BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YNL133C::YNL133C-TAP-KanMX
Open
Biosystems
WT, RNH1
over-expression
BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0; pRS 315
pGAL1-3HA RNase H1
Euroscarf
bye1∆, RNH1
over-expression
BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YKL005C::KanMX; pRS 315 pGAL1-3HA RNase H1
Euroscarf
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paf1∆, RNH1
over-expression
BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YBR279W::clonNAT; pRS 315 pGAL1-3HA RNase H1
this work
tho2∆, RNH1
over-expression
BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YNL139C::clonNAT; pRS 315 pGAL1-3HA RNase H1
this work
fyv6∆, RNH1
over-expression
BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YNL133C::clonNAT; pRS 315 pGAL1-3HA RNase H1
this work
bye1∆paf1∆,
RNH1
over-expression
BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YKL005C::KanMX; YBR279W::clonNAT; pRS 315 pGAL1-3HA
RNase H1
this work
bye1∆tho2∆,
RNH1
over-expression
BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YKL005C::KanMX; YNL139C::clonNAT; pRS 315 pGAL1-3HA
RNase H1
this work
bye1∆fyv6∆,
RNH1
over-expression
BY4741; MATa; his3D1; leu2D0; met15D0; ura3D0;
YKL005C::KanMX; YNL133C::clonNAT; pRS 315 pGAL1-3HA
RNase H1
this work
* dst1 encodes the general transcription factor TFIIS
6.3 Plasmids and oligonucleotides
Table 6: Plasmids used in this study
Vector ID Insert/Description type tag primer (fwd+rev)
KK17 Sc Bye1 1-596 (=full-length) pOPINF N-His KK41+KK44
KK51 Sc Bye1 69-370, 3C to purify
TLD
pOPINI N-His KK121/133+KK122/134
(inserted 3C site by
overlapping PCR)
Sc Gal4-VP16 pET21b N-His (cloned by M. Seizl)
native HIS4 promoter (-428 to
+24 respective to the A in the
start codon)
pBlue-
script II
KS+
(cloned by L. Lariviere)
Sc TFIIS domain II+III (aa
131-309)
pET 28a N-His (cloned by H. Kettenberger)
KK101 pGAL1-3HA RNase H1 pRS 315 N-HA KK286-289
Table 7: Oligonucleotides used for molecular cloning
Primer ID Primer name Sequence (5'-3')
KK41 Bye1 FL fwd AAGTTCTGTTTCAGGGCCCGATGTCTGTCCGTAC-
TTCTTCAAGA
KK44 Bye1 FL rev ATGGTCTAGAAAGCTTTAATGGATAAATTCCTGTTTCACGA
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KK71 bye1∆ conﬁrmation
fwd
ATATGAACACTGATGGGCACTTTAT
KK74 bye1∆ conﬁrmation
rev
GAAAGCCTCTGTTATTCACACATCT
KK121 Bye1 PHD 3C TLD
fwd
TGCCTCTTGAAGTCCTCTTTCAGGGACCCACTAG-
GAAAGATTTTGAAAGCGAAA
KK122 Bye1 PHD 3C TLD
rev
CTAGTGGGTCCCTGAAAGAGGACTTCAAGAGGCA-
TTTCGTTTTCGGCAGTATCA
KK129 bye1∆ kanMX fwd TTATCCTAGGTTCTCTTTTACTTTTAGCTTTTATTT-
AGTTTAAATTTATTCGGATCCCCGGGTTAATTAAGGCGC
KK130 bye1∆ kanMX rev TTTGTTATCATATTACTATAATATTGTTACAACTCT-
TAGGAATCTTATATGAATTCGAGCTCGTTTAAACTGGAT
KK133 Bye1 69 fwd ACCATCACAGCAGCGGCATGGATGAGGGCTATG-
TTAGATGTCTG
KK134 Bye1 370 rev ATGGTCTAGAAAGCTTTATTGTCAGGTACCTCCACGATAAAA
KK165 paf1∆ conﬁrmation
fwd
ATATCGAAGTTGACCATACGAAAAG
KK173 tho2∆ clonNAT
fwd
AACGGTTTCAGTTGATACATATTCGCACCAGTATA-
CATTTTCAGGACTTTTAACCTTATGTATCATACACA-
TACGATTTAGGTGAC
KK174 tho2∆ clonNAT rev CTATCAAAGTACACGTTAAAATTCAGCTCGGGTAT-
GTTAAGTACTAGTAATTAGGGGCAGGGCATGCTCATGTAG
KK201 paf1∆ clonNAT fwd AATGTATTCAGTACAATAGAACAGTGCTCATAATA-
GTATAAAGGGTCACATAACCTTATGTATCATACAC-
ATACGATTTAGGTGAC
KK202 paf1∆ clonNAT rev GTAAAAAGAACTACAGGTTTAAAATCAATCTCCCT-
TCACTTCTCAATATTTTAGGGGCAGGGCATGCTCATGTAG
KK212 tho2∆ conﬁrmation
fwd
ATTTACATGTTCTGAATGAGAAGGC
KK290 tho2∆ conﬁrmation
rev
CGATAAAAGAAAGAACGGTTTGTTA
KK291 paf1∆ conﬁrmation
rev
TATTTGTGTCAGTGTAACTGCTGGT
KK123 Bye1 ko ClonNAT
fwd
TTATCCTAGGTTCTCTTTTACTTTTAGCTTTTATTT-
AGTTTAAATTTATTTAACCTTATGTATCATACACAT-
ACGATTTAGGTGAC
KK124 Bye1 ko ClonNAT
rev
TTTGTTATCATATTACTATAATATTGTTACAACTCT-
TAGGAATCTTATATTTAGGGGCAGGGCATGCTCATGTAG
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KK125 Dst1 ko ClonNAT
fwd
CAAGCAGCAGAACATTCACAGTGTAGTCAGTCCG-
CATAAGAGCATTCATCTAACCTTATGTATCATACAC-
ATACGATTTAGGTGAC
KK126 Dst1 ko ClonNAT
rev
TCCTATTGTTTCCTTTGCTCTGTCCGTGGCTACTC-
TCATCTTTTTCTATTTTAGGGGCAGGGCATGCTCATGTAG
KK138 Dst1 ko
conﬁrmation fwd
GGTTCTCTTAGGAAATTCTAAACGC
KK141 Dst1 ko
conﬁrmation rev
ACGAACAAAAGATTTTACGTGAGAC
KK164 Fyv6 ko
conﬁrmation fwd
GATATACCTGGGAAGTTACAATGGA
KK165 Fyv6 ko
conﬁrmation rev
ATATCGAAGTTGACCATACGAAAAG
KK244 Bye1 KanMX6-
PGAL1-3HA
fwd
ATCAGAAAACCACTTTGTAACAAATATGAACACTG-
ATGGGCACTTTATTATTCTTTGACAGAAAGAAATA-
AAAAAGCGATGAATTCGAGCTCGTTTAAACTGGATG
KK245 Bye1 KanMX6-
PGAL1-3HA
rev
GCTTCAGTCTCCTCCTGTAACAAATACTCAATATAT-
TTATTCTGACCCTTATTAGATCTTGAAGAAGTAC-
GGACAGAAGCGTAATCTGGAACGTCATATGG
KK286 pGAL1 3HA RNH1
fwd
agctccaccgcggtggcggccgcACGGATTAGAAGCCGCCG
KK287 pGAL1 3HA RNH1
rev
ttcctgcagcccgggggatccTTATCGTCTAGATGCTCCTTTC
KK288 pGAL1 3HA RNH1
overlap fwd
GTTCCAGATTACGCTATGGCAAGGCAAGGGAAC
KK289 pGAL1 3HA RNH1
overlap rev
GTTCCCTTGCCTTGCCATAGCGTAATCTGGAAC
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Table 8: Oligonucleotides used for crystallization and assays
type sequence 3'-5' application
template DNA TTA CTG GBC CTT ATT CAT GAA CTC GA
tailed templatenon-template DNA TC GAG TTC ATG AAA
RNA AG GAC CAG CUU
template DNA CAA TCT CGT BGT GGT CCA TTC GAT CGA
arrest template
non-template DNA TCG ATC GAA TGG AG
pSH515-5'Cy5 CTC GAA CCG ACA ACG GGC AGA GTG ACC ACT
T-Cy5
transcription assay
template DNA TTG CTG GTC CGG ATT CAT GAA CTC GA
mismatch templatenon-template DNA TC GAG TTC ATG AAT
RNA AG GAC CAG CUU UAC UU
6.4 Reagents and consumables
Chemicals were obtained from Merck (Darmstadt, Germany), Roth (Karlsruhe, Germany) or
Sigma-Aldrich (Seelze, Germany), unless stated otherwise. Enzymes and reagents for cloning
were obtained from Fermentas (St. Leonrot, Germany), New England Biolabs (Frankfurt am
Main, Germany) and Clontech (St Germain-en-Leye, France). For DNA preparation, com-
mercial kits from Qiagen (Hilden, Germany) were used. DNA and RNA oligonucleotides were
ordered at ThermoScientiﬁc (Ulm, Germany) and Metabion (Planegg, Germany), respectively.
Crystallization reagents and tools were ordered at Hampton Research (Aliso Viejo, CA, USA)
and Qiagen (Hilden, Germany). Reagents and consumables were ordered at standard laboratory
suppliers.
6.5 Media and additives
Table 9: Media for E.coli and S.cerevisiae
Media Application Description
LB E.coli culture 1% (w/v) tryptone; 0.5% (w/v) yeast extract; 0.5% (w/v)
NaCl
SOB E.coli transformation 2% (w/v) tryptone; 0.5% (w/v) yeast extract; 8.55 mM
NaCl; 2.5 mM KCl; 10 mM MgCl2
SeMet E.coli culture 22 g/l SeMet base; 5 g/l nutrient mix; 40 µg/ml SeMet (all
components Molecular Dimensions)
YPD Yeast culture 2% (w/v) peptone; 2% (w/v) glucose; 1% (w/v) yeast
extract
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YPDS Yeast culture 2% (w/v) peptone; 2.2% (w/v) glucose; 1% (w/v) yeast
extract; 18.25% (w/v) Sorbitol
YPGal Yeast culture 2% (w/v) peptone; 2% (w/v) galactose; 1% (w/v) yeast
extract
SC Yeast culture 0.69% (w/v) nitrogen base; 0.6% (w/v) CSM amino acid
drop-out mix; 2% (w/v) glucose
GNA SL screen 3% (w/v) Difco nutrient broth; 1% (w/v) yeast extract;
2.5% (w/v) agar; 5% (w/v) glucose; 20 µg/ml tetracycline
sporulation
media
SL screen 0.1% (w/v) yeast extract; 2.5% (w/v) agar; 2% (w/v)
glucose; 1% (w/v) K Acetate; 30 mg/L histidine; 30 mg/L
uracil; 30 mg/L leucin; 20 µg/ml tetracycline
SD-H SL screen 0.17% (w/v) yeast nitrogen base w/o aa w/o (NH4)2SO4;
2.5% (w/v) agar; 2% (w/v) glucose; 0.5% (w/v)
(NH4)2SO4; 0.2% (w/v) drop-out powder w/o histidine,
arginine, leucine; 50 µg/ml Canavanine; 50 µg/ml
S-(2-NH2ethyl)-L-Cys; 20 µg/ml tetracycline
Table 10: Media additives for E.coli and S.cerevisiae
Additive Description Stock solution applied concentration
IPTG E.coli induction 1 M in H2O 0.25-0.5 mM
Ampicillin Antibiotic 100 mg/ml in H2O 100 µg/ml
Chloramphenicol Antibiotic 50 mg/ml in EtOH 50 µg/ml
6-AU reduction of
ribonucleotide levels
100 mg/ml in DMSO 50-200 µg/ml
MPA reduction of
ribonucleotide levels
powder 15-45 µg/ml
HU replication fork
stalling
powder 100-200 mM
Phleomycin DNA intercalation 20 mg/ml 1.0-1.5 µg/ml
Etoposide Topoisomerase II
inhibition
powder 0.1-0.25 mM
MMS replication fork
stalling
100% 0.01-0.02% (v/v)
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6.6 Buﬀers and solutions
Table 11: General buﬀers, dyes and solutions
Name Description/Source Application
Electrophoresis buﬀer NuPAGE buﬀer, life technologies SDS-PAGE
5X SDS sample buﬀer 250 mM Tris, pH 6.8 at 20°C; 50% (v/v) glycerol; 0.03%
(w/v) bromophenol blue; 7.5% (w/v) SDS; 100 mM DTT
SDS-PAGE
Gel staining solution Instantblue, expedion Coomassie
staining
Silver nitrate solution 0.2% AgNO3, 0.05% formalin (35% formaldehyde) Silver staining
Developing solution 6% Na2CO3; 0.05% formalin (35% formaldehyde) Silver staining
Transfer buﬀer NuPAGE TransferBuﬀer, life technologies Western blotting
PBS buﬀer 137 mM NaCl; 2.7 mM KCl; 10 mM Na2HPO4; 1.76 mM
KH2PO4; pH 7.4
Western blotting
100X PI 0.028 mg/ml leupeptin; 0.137 mg/ml pepstatin A; 0.017
mg/ml PMSF; 0.33 mg/ml benzamidine; in 100% EtOH p.a.
Protease
inhibitor mix
10X TAE 50 mM EDTA, pH 8.0; 2.5 M Tris-acetate Agarose gels
TE 1 mM Tris pH 8.0 at 20°C; 0.1 mM EDTA dissolving DNA
2X transcription buﬀer 40 mM HEPES, pH 7.6; 120 mM (NH4)2SO4; 16 mM
MgSO4; 20 µM ZnCl2; 20 % (v/v) glycerol; 20 mM DTT
RNA extension
assay
10X TBE 900 mM Tris; 900 mM boric acid; 20 mM EDTA, pH 8.0 RNA extension
assay
2X urea loading buﬀer 20 % (v/v) 10 Ö TBE; 8 M RNase free urea Urea PAGE
2X urea loading dye 20 % (v/v) 10 Ö TBE; 8 M RNase free urea; 0.03 % (w/v)
bromophenol blue; 0.03 % (w/v) xylene cyanol FF
Urea PAGE
5X Acetate
transcription buﬀer
500 mM KAc, pH 7.6; 100 mM HEPES, pH 7.6; 5 mM
EDTA; 25 mM MgOAc
Transcription
assay
5X primer annealing
buﬀer
25 mM Tris, pH 8.3 at 20°C; 375 mM KCl; 5 mM EDTA, pH
8
Transcription
assay
5X synthesis buﬀer 250 mM Tris, pH 8.3 at 20°C; 375 mM KCl; 22.5 mM
MgCl2; 75 mM DTT
Transcription
assay
TFB-I 30 mM KaAcetate; 50 mM Mn2Cl; 100 mM RbCl; 10 mM
CaCl2; 15 % (v/v) glycerol
Chemically
competent E.coli
TFB-II 10 mM MOPS, pH 7.0; 75 mM CaCl2; 10 mM RbCl; 15%
(v/v) glycerol
Chemically
competent E.coli
TeLit, pH 8.0 155 mM LiOAc; 10 mM Tris, pH 8.0 at 20°C; 1 mM EDTA,
pH 8.0
chemically
competent yeast
cells
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LitSorb 18.2% (w/v) Sorbitol in TeLit, pH 8.0 chemically
competent yeast
cells
LitPEG 40% (w/v) PEG 3350 in TeLit, pH 8.0 chemically
competent yeast
cells
One-step buﬀer 0.2 M LiOAc; 40% (w/v) PEG 3350; 100 mM DTT chemically
competent yeast
cells
Table 12: Pol II puriﬁcation buﬀers
Name Description
3X freezing buﬀer 150 mM Tris, pH 7.9 at 4°C; 3 mM EDTA; 30 μM ZnCl2; 30 % (v/v)
glycerol; 3 % (v/v) DMSO; 30 mM DTT; 3X PI
HSB150 50 mM Tris, pH 7.9 at 4°C; 150 mM KCl; 1 mM EDTA; 10 μM ZnCl2; 10 %
(v/v) glycerol; 10 mM DTT; 1X PI
HSB1000/7 50 mM Tris, pH 7.9 at 4°C; 1000 mM KCl; 7 mM imidazole; 1 mM EDTA; 10
μM ZnCl2; 10 % (v/v) glycerol; 2.5 mM DTT; 1X PI
Ni buﬀer 20 mM Tris, pH 7.9 at 4°C; 150 mM KCl; 7/50/100 mM imidazole
MonoQ 150 20 mM Tris-acetate, pH 7.9 at 4°C; 150 mM KOAc; 10 % (v/v) glycerol; 0.5
mM EDTA, pH 7.9; 10 μM ZnCl2; 10 mM DTT
MonoQ 2000 20 mM Tris-acetate, pH 7.9 at 4°C; 2000 mM KOAc; 10 % (v/v) glycerol; 0.5
mM EDTA, pH 7.9; 10 μM ZnCl2; 10 mM DTT
Pol II buﬀer 5 mM HEPES, pH 7.25; 40 mM (NH4)2SO4; 10 µM ZnCl2; 10 mM DTT
Table 13: Nuclear extract preparation buﬀers
Name Description
Resuspension buﬀer 50 mM Tris, pH 7.5 at 4°C; 20 mM EDTA; 30 mM DTT
Cell lysis buﬀer 18% Polysucrose 400; 10 mM Tris, pH 7.5 at 4°C; 20 mM K Acetate; 5 mM
Mg Acetate; 1 mM EDTA pH 8.0; 0.5 mM Spermidine; 0.15 mM Spermine; 3
mM DTT; 1X PI
Centrifugation buﬀer 100 mM Tris, pH 7.9 at 4°C; 50 mM K Acetate; 10 mM MgSO4; 20%
Glycerol; 2 mM EDTA
Dialysis buﬀer 20 mM HEPES, pH 7.6; 10 mM MgSO4; 1 mM EGTA, pH 8.0; 20% Glycerol
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Table 14: Peptide array buﬀers
Name Description
printing buﬀer 1X protein printing buﬀer (Arrayit), 1% (w/v) BSA, 5 mg/mL
ﬂuorescein-labeled biotin
hybridization buﬀer PBS, pH 7.6; 5% (w/v) BSA, 0.1% Tween-20
Table 15: Chromatin immunoprecipitation buﬀers
Name Description
TBS 20 mM Tris, pH 7.5 at 4°C; 150 mM NaCl
FA-lysis buﬀer 50 mM HEPES, pH 7.5; 150 mM NaCl; 1 mM EDTA; 1% (v/v) Triton X-100;
0.1% (v/v) Na deoxycholate; 0.1% (v/v) SDS
ChIP wash buﬀer 10 mM Tris, pH 8 at 4°C; 0.25 M LiCl; 1 mM EDTA; 0.5% (v/v) NP-40;
0.5% (v/v) Na deoxycholate
ChIP elution buﬀer 50 mM Tris, pH 7.5 at 25°C; 10 mM EDTA; 1% (v/v) SDS
7 Methods
7.1 General methods
7.1.1 Preparation and transformation of competent cells
Chemically competent E.coli cells for cloning Chemically competent E.coli cells were
prepared from LB pre-cultures grown at 37°C ON. 400 ml LB medium (supplemented with
antibiotics if required) was inoculated with the pre-culture and grown at 37°C until an OD600
of 0.5 was reached. Cultures were then cooled down on ice and centrifuged for 10 min at 4,000
rpm at 4°C. Pellets were resuspended in 100 ml TFB-I on ice and centrifuged as before. Pellets
were then resupended in 8 ml TFB-II on ice. 50 µl aliquots were prepared and immediately
frozen in liquid nitrogen.
Cells were transformed by heat-shock using 100 ng vector, or 2.5 µl InFusion product. Cells
were incubated on ice for 5 min prior to heat-shock at 42°C for 90 s. Cells were then cooled
on ice for 5 min and grown in 1 ml LB medium at 37°C for 1 hour shaking in a thermomixer
(Qiagen) for recovery. Finally, cells were plated on selective plates and incubated ON at 37°C.
Electro-competent E.coli cells for protein expression Electro-competent E.coli cells
were prepared LB pre-cultures grown at 37°C ON. 1 L SOB medium (supplemented with
antibiotics if required) was inoculated with the pre-culture and grown at 37°C until an OD600
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of 0.5 was reached. Cultures were then cooled down on ice and centrifuged for 10 min at 4,000
rpm at 4°C. Pellets were resuspended in 100 ml ice-cold and sterile H2O and centrifuged as
before. Pellets were then resusupended in 8 ml ice-cold 10% glycerol (v/v). 50 µl aliquots
were prepared and immediately frozen in liquid nitrogen.
Cells were transformed by electroporation using 100 ng vector. Cells were incubated in a
cuvette on ice for 5 min prior to electroporation. Electroporation was carried out at 2.5 kV
in a MicroPulser Electroporator (Biorad). Cells were then cooled on ice for 5 min and grown
in 1 ml LB at 37°C for 1 hour shaking in a thermomixer (Qiagen) for recovery. Finally, cells
were plated on selective plates and incubated over night at 37°C, or were used directly for
inoculation of pre-cultures.
Chemically competent yeast cells for homologous recombination Chemically com-
petent S.cerevisiae cells were prepared from YPD pre-cultures grown at 30°C ON. 50 ml YPD
medium was inoculated with the pre-culture at a starting OD600 of 0.2 and grown at 30°C
until an OD600 of 0.5 was reached. Cultures were then centrifuged for 5 min at 4,000 rpm
at RT. Pellets were resuspended in 25 ml sterile H2O, 5 ml LitSorb and 360 µl LitSorb, with
centrifuging inbetween. Salmon sperm DNA was boiled for 10 min and immediately cooled
down on ice. 40 µl salmon sperm DNA was added to the cell solution and 50 µl aliquots were
prepared for immediate use.
Cells were transformed by adding 1 µg PCR product to 50 µl competent cells. 360 µl
LitPEG was added and the mixture was incubated for 30 min at RT. 47 µl DMSO was added
and the mixture was incubated for 15 min at 42°C, before spinning down for 3 min at 2,000
rpm at RT. Cells were then resuspended in 1 ml YPD and grown at 30°C for 3 h shaking in a
thermomixer (Qiagen) for recovery. Finally, cells were plated on selective plates and incubated
for 2-3 days at 30°C.
Chemically competent yeast cells for plasmid transformation Chemically competent
S.cerevisiae cells were prepared from fresh YPD plates grown ON. A small amount of cells was
resuspended in 1 ml sterile H2O and spun down at 13,000 rpm for 1 min. The pellet was then
resuspended in 100 µl One-step buﬀer and vortexed vigorously. Salmon sperm DNA was boiled
for 10 min, immediately cooled down on ice and 10 µl were added to the cell solution. After
addition of 500 ng plasmid DNA, cells were incubated for 30 min at 45°C. Cells were washed
with 1 ml YPD and immediately plated on selective plates and incubated for 2-3 days at 30°C.
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7.1.2 Molecular cloning
Polymerase Chain Reaction Primers for InFusion cloning (Clontech) were designed using
an overhang of 15-20 nucleotides at the 5' end, followed by 20 nucleotides complementary to
the gene of interest. Puriﬁcation tags and protease cleavage sites were introduced either by
in-frame cloning into according vectors or by PCR. Protease cleavage sites within the gene
of interest were introduced by overlapping PCR. For this, two overlapping PCR products are
synthesized with primers carrying the desired protease cleavage site. In a second PCR reaction,
these products were used as template to synthesize the gene of interest containing the protease
cleavage site. PCR reactions were carried out using the Phusion High Fidelity PCR Master
Mix (NEB), 0.5 µM of each primer, 5% (v/v) DMSO and variable amounts of DNA template,
either genomic or plasmid DNA.
Thermocycling programs comprised 30 cycles and were adjusted to the speciﬁc needs of the
individual reactions in terms of annealing temperature and elongation times (Biometra T3000
Thermocycler). PCR products were visualized on 0.5-1% (w/v) agarose gel electrophoresis and
staining with Sybr Safe (Invitrogen). Puriﬁcation of PCR products was carried out using the
QIAquick gel extraction kit (Qiagen).
Enzymatic restriction cleavage Vectors were digested using restriction endonucleases
(NEB, Fermentas) as recommended by the manufacturer. Cleaved vectors were puriﬁed using
the QIAquick PCR puriﬁcation kit (Qiagen).
Restriction- and Ligation-free InFusion cloning InFusion cloning (Clontech) allows for
restriction and ligation-free cloning. 50 ng of digested vector, 3 fold molar amount of insert,
and InFusion reaction mixture was incubated as recommended by the manufacturer. 2.5 µl of
InFusion reaction were then transformed as described in 7.1.1.
Homologous recombination In order to insert protein tags genomically or delete genes of
interest in yeast, homologous recombination in vivo was carried out. For deletion of genes,
cassettes containing a resistance marker with 25 bp homologous to the up- and downstream
region of the gene of interest at it's 5' and 3' end were synthesized by PCR and transformed
into yeast as described in 7.1.1. For insertion of protein tags, cassettes were synthesized as
above, additionally containing sequences for protein tags.
After transformation into yeast cells, single colonies were re-streaked on selective plates
and grown for 2-3 days at 30°C. A small amount of cells was then resuspended in 100 µl 0.2 M
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NaOH, and 50 µl Zirconia beads (Biospec) were added. The mixture was incubated at 95°C
for 5 min in a thermomixer at maximum speed. The mixture was then centrifuged for 5 min
at max speed and 5 µl of supernatant were used as template for a PCR reaction carried out as
described in 7.1.2 to conﬁrm correct genomic insertion.
Isolation and veriﬁcation of plasmid DNA After transformation of plasmids into E.coli
cells, single colonies from selective plates were picked and used for colony PCRs. For this,
colonies were inoculated in 30 µl H2O and mixed for 10 min at RT in a thermomixer. 6 µl of
the mixture were then used as template for a PCR reaction carried out as described in 7.1.2.
Colonies resulting in positive PCR reactions were used to inoculate 5 ml ON cultures. Plasmids
were isolated from ON cultures using Miniprep puriﬁcation kits (Qiagen) and were veriﬁed by
sequencing (GATC).
After transformation of plasmids into yeast cells, single colonies were re-streaked on selective
plates and grown for 2-3 days at 30°C to conﬁrm successful transformation.
Electrophoretic separation of DNA Electrophoretic separation of DNA was carried out in
horizontal 1X TAE agarose gels containing 0.7 µg/ml Sybr Safe (Invitrogen) and varying con-
centrations of agarose, depending on the size of the molecules to be separated. Separation was
carried out in PerfectBlue Gelsystem electrophoresis chambers (Peqlab). Samples were mixed
with 6X loading dye (Fermentas) prior to loading and DNA was visualized and documented
using a Safe Imager blue light transilluminator (Invitrogen, λ=470 nm).
7.1.3 Over-expression of proteins in S.cerevisiae
For genomic over-expession, a cassette containing the Gal-promoter sequence and a 3X HA
tag sequence was introduced upstream of the ORF by homologous recombination (described
in 7.1.1). For over-expression from a plasmid, the Gal-promoter sequence, the 3X HA tag
sequence and the ORF of the protein of interest were cloned into pRS315 and the plasmid was
transformed into S.cerevisiae as described in 7.1.1. Expression was induced by growing trans-
formed cells in YPGal medium and conﬁrmed by Westernblotting using an anti-HA antibody
(Roche) as described in 7.1.5.
7.1.4 Protein expression in E.coli
Recombinant proteins were expressed in E.coli BL21-CodonPlus (DE3) RIL. For this, plasmids
encoding proteins of interest were transformed as described in 7.1.1. Cells were grown in
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LB medium containing required antibiotics at 37°C until an OD600 of 0.8-0.9 was reached.
Expression was then induced by addition of varying amounts of IPTG and shifting cells to 20°C
for 18 h. Cells were harvested by centrifugation at 4,000 rpm for 10 min and pellets were
stored at -20°C.
7.1.5 Protein analysis
Determination of protein concentration Total protein concentrations were determined
measuring the absorption at 280 nm using a ND-100 (NanoDrop) spectrophotometer. Indi-
vidual molar absorption coeﬃcients of proteins measured were calculated using the ProtParam
software (Gasteiger et al., 2005). If samples contained large amounts of non-protein molecules
absorbing at 280 nm, such as nucleic acids and detergents, protein concentrations were de-
termined by Bradford assay (Bradford, 1976). For this, the dye reagent (BioRad) was used
according to manufacturer's instructions and samples were measured at 595 nm. Reference
curves were generated for each new batch of dye reagent using bovine serum albumin (Fraction
V, Roth).
SDS-Polyacrylamide gel electrophoresis Electrophoretic separation of proteins was car-
ried out using Novex NuPAGE gradient SDS-PAGE (life technologies) according to manufac-
turer's instructions. Gels were stained with Instantblue (expedion) for up to 1 hour before
transferring to H2O. For more sensitive detection of proteins, silver staining was applied. For
this, the gel was ﬁxed in 50% Ethanol for 20 min, followed by 5% Ethanol for another 20 min.
After incubating for 5 min in 35 µM DTT, the gel was sensitized in silver nitrate solution for 10
min, washed twice with H2O and developed in developing solution. The reaction was stopped
by addition of 5% HOAc.
Western blotting and immunostaining For western blotting and immunostaining, protein
samples were separated on a SDS-PAGE as described (7.1.5). Western blotting onto a PVDF
Immobilon membrane (Millipore) was carried out using a Trans-Blot transfer cell (Biorad) at
150 V for 90 min at 4°C. The membrane was blocked for 20 min at RT with 2% milk (w/v)
in 1X PBS containing 0.02% Tween 20 (PBS-T), followed by incubation with the primary
antibody in 2% milk in PBS-T for 60 min. The membrane was then washed 3X for 5 min with
2% milk in PBS-T before incubating with the secondary antibody for 60 min. After washing
the membrane as described before, Pierce ECL Western Blotting Substrate (Thermo Scientiﬁc)
was added and Amersham Hyperﬁlms ECL (GE Healthcare) were developed until clear signals
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appeared.
7.1.6 Scaﬀold preparation
To anneal DNA-RNA-scaﬀolds for crystallization and in vitro assays, oligonucleotides were dis-
solved separately in TE at a ﬁnal concentration of 400 µM. Equimolar amounts of non-template
DNA, template DNA and RNA were mixed and TE was added to reach a ﬁnal concentration
of 100 µM. Scaﬀolds were annealed in a Thermocycler (Biometra T3000 Thermocycler) using
the following program:
time (s) Temp or ∆Temp
preheat lid 99°C
90 95°C
90 95°C
90 -1°C 75 cycles
∞ 4°C
Annealed scaﬀolds were stored at -20°C.
7.1.7 Crystallization screening
Initial crystallization screening was performed by the Crystallization Facility at the MPI of
Biochemistry, Martinsried. Using various commercial as well as in-house produced screens,
sitting-drops were set up at 20°C with a drop size of 100 nl. Initial crystals were reﬁned
in 48-well sitting drop plates (Molecular Dimensions) manually by varying pH, precipitant,
concentration of components, temperature and drop-size.
7.1.8 Bioinformatic tools
Protein and gene sequences were retrieved from the NCBI or Saccharomyces cerevisiae gen-
ome (SGD) databases. Sequence data was visualized and processed using Ape (Davis &
Hammarlund, 2006). Bioinformatic analysis was performed using the Bioinformatic Toolkit
(Biegert et al., 2006). Multiple sequence alignments were generated using MUSCLE (Edgar,
2004) and Aline (Bond & Schüttelkopf, 2009). Protein secondary structures were predicted by
HHpred (Söding et al., 2005) and psipred (Jones, 1999).
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7.2 Speciﬁc methods
7.2.1 Protein expression and puriﬁcation
Expression and puriﬁcation of recombinant full-length Bye1 Full-length Bye1 was
cloned into pOPINF with an N-terminal hexahistidine tag and expressed in E. coli BL21 (DE3)
(Novagen). Protein expression was carried out as described in 7.2.1 and expression was induced
with 0.25 mM IPTG. Protein was puriﬁed by nickel aﬃnity, anion exchange and size-exclusion
chromatography. Cells were lysed by sonication in buﬀer A (20 mM Tris, pH 7.5 at 20°C;
100 mM NaCl; 10 µM ZnCl2; 10% (v/v) glycerol; 5 mM DTT), supplemented with 20 mM
imidazole, 1 u/µl DNase (Fermentas) and 1X PI. After centrifugation at 16,000xg for 20 min,
the cleared lysate was applied to a pre-equilibrated (buﬀer A) Ni-NTA agarose column (Qiagen).
The column was washed with 10 CV of buﬀer A containing 20 mM imidazole before step-wise
elution of the protein with buﬀer A containing 50/100/200 mM imidazole. Fractions containing
Bye1 were pooled and applied to a MonoQ 10/100 GL column (GE healthcare) equilibrated in
buﬀer A. The protein was eluted with a linear gradient from 100 mM to 1 M NaCl (buﬀer B:
20 mM Tris, pH 7.5 at 20°C; 1 M NaCl; 10 µM ZnCl2; 10% (v/v) glycerol; 5 mM DTT) over
10 CV. To remove any minor contaminants a ﬁnal size exclusion step using a Superdex 200
10/300 GL column (GE Healthcare) in buﬀer A was carried out.
Expression and puriﬁcation of recombinant Bye1 TLD Bye1 TLD (residues 225-370)
was expressed as a larger variant (residues 69-370) containing a protease cleavage site at the
N-terminal border of the TLD, cloned into pOPINI with an N-terminal hexahistidine tag. The
protein was expressed and puriﬁed as above except that expression was induced with 0.5 mM
IPTG, buﬀers did not contain glycerol and the protein was eluted from the Ni-NTA column
with 200 mM imidazole. After ion exchange puriﬁcation, 300 µg precision protease was added
and cleavage was carried out ON at 4°C. To separate the cleavage products, the protein was
applied to a pre-equilibrated (buﬀer A) Ni-NTA column. Bye1 TLD could be collected in the
ﬂow-through fraction and was then applied to size-exclusion chromatography using a Superdex
75 10/300 GL column (GE Healthcare).
Expression and puriﬁcation of selenomethionine-substituted Bye1 Selenomethionine
(SeMet)-substituted Bye1 was expressed in SeMet medium (6.5). 2 l of SeMet medium were
inoculated with an ON preculture and grown at 37°C until an OD600 of 0.6 was reached.
Temperature was reduced to 20°C and after 30 min, 25 µg/ml SeMet, 50 µg/ml Lys/Thr/Phe,
25 µg/ml Leu/Ile/Val and 0.25 mM IPTG were added. Expression was carried out ON and
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protein puriﬁcation was performed as described above.
Puriﬁcation of endogenous RNA Polymerase II
Fermentation 50 ml YPD preculture were inoculated from a fresh plate and incubated
shaking for 10 h at 30°C. 500 ml YPD preculture were inoculated with 25 ml of the previous
preculture and incubated shaking for 14 h at 30°C. 15-17 l YPD culture were inoculated with
500 ml of the second preculture and grown in a small fermenter for 10-11 h at 30°C, stirring
at 600 rpm and with an air supply of 800 l/h. 200 l YPD culture were then inoculated with
a starting OD600 of 0.2 and grown at 30°C stirring at 200 rpm with an air supply of 25 l/h in
a large fermenter until OD600 of 8.5 was reached. Cells were harvested using a ﬂow-through
centrifuge. 1 kg of cell pellet was resuspended in 330 ml 3X freezing buﬀer at 4°C, ﬂash-frozen
in liquid nitrogen in 200 ml aliquots and stored at -80°C.
Protein puriﬁcation Cells were lysed using a bead beater (Hamilton Beach) ﬁlling 200
ml of cell suspension, 200 ml of glass beads and 1 ml 100X PI into a metal chamber. Lysis
was carried out for 80 min at 4°C with cycles of 30 s on, 90 s oﬀ. Cell lysate was centrifuged
twice for 30 min at 9,000 rpm at 4°C and ultracentrifuged for 90 min at 24,000 rpm at 4°C.
Proteins were then precipitated with 50% (w/v) (NH4)2SO4 stirring ON at 4°C, followed by
centrifugation twice for 45 min at 15,000 rpm at 4°C. The pellet was resuspended in 140 ml
HSB 150 per 100 g pellet and conductivity was set to that of buﬀer HSB1000/7. The sample
was then applied to pre-equilibrated Ni-NTA resin, washed with 5 CV HSB 1000/7 and 3 CV
Ni buﬀer 7, and eluted with 3 CV Ni buﬀer 50 and 3 CV Ni buﬀer 100. Elution fractions
were pooled and conductivity was adjusted to that of buﬀer MonoQ150. Sample was loaded
to a pre-equilibrated MonoQ 10/100 (GE Healthcare) and eluted with a linear gradient over
12 CV to 75% buﬀer MonoQ2000. Fractions containing Pol II were pooled, diluted with 3 V
Pol II buﬀer and concentrated to around 1 ml. 4-fold molar excess of Rpb 4/7 (for puriﬁcation
protocol, see 7.2.1) was added and incubated on ice for 45 min. Sample was applied twice
to a pre-equilibrated Superose 6 10/300 (GE Healthcare) and fractions containing Pol II were
concentrated to 3.0-3.4 mg/ml, ﬂash-frozen in liquid nitrogen in 20 µl aliquots and stored at
-80°C.
Expression and puriﬁcation of Rpb4/7 Protein expression was carried out as described
in 7.2.1 and expression was induced with 0.5 mM IPTG. Cells were lysed by sonication in buﬀer
A (50 mM Tris, pH 7.5 at 4°C; 150 mM NaCl; 10 mM ß-mercaptoethanol) containing 1X PI.
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After centrifugation at 16,000xg for 20 min, the cleared lysate was applied to a pre-equilibrated
(buﬀer A) Ni-NTA agarose column (Qiagen). The column was washed with 5 CV buﬀer A, 3
CV buﬀer A containing 2 M NaCl, 3 CV buﬀer A containing 10 mM imidazole and 3 CV buﬀer
A containing 20 mM imidazole. The protein was eluted with 3 CV buﬀer A containing 50 mM
imidazole and 6 CV buﬀer A containing 200 mM imidazole. Fractions containing Rpb4/7 were
pooled and applied to a Source15Q 16/10 column (GE healthcare) equilibrated in buﬀer A
containing 100 mM NaCl. The column was washed with 10 CV buﬀer A containing 100 mM
NaCl and the protein was eluted with a linear gradient to 1 M NaCl over 10 CV. To remove any
minor contaminants, a ﬁnal size exclusion step using a HiLoad 26/60 Superdex75 pg column
(GE Healthcare) in Pol II buﬀer was carried out.
Expression and puriﬁcation of TFIIS domain II+III TFIIS domain II+III (aa 131-309)
was cloned into pET 28a with an N-terminal hexahistidine tag and expressed in E. coli BL21
(DE3) (Novagen). Protein expression was carried out as described in 7.2.1 and expression was
induced with 0.5 mM IPTG. Protein was puriﬁed by nickel aﬃnity and anion exchange. Cells
were lysed by sonication in buﬀer A (25 mM HEPES, pH 7.5 at 20°C; 300 mM NaCl; 5 µM
ZnCl2; 2.5% (v/v) glycerol; 10 mM DTT), supplemented with 20 mM imidazole, 1 u/µl DNase
(Fermentas) and 1X PI. After centrifugation at 15,000xg for 30 min, the cleared lysate was
applied to a pre-equilibrated (buﬀer A + 500 mM NaCl) Ni-NTA agarose column (Qiagen).
The column was washed with 10 CV of buﬀer A containing 20 mM imidazole before elution
of the protein with buﬀer A containing 500 mM NaCl and 500 mM imidazole in 5 CV. Elution
fraction was 5X diluted to 100 mM NaCl and applied to a MonoQ 10/100 GL column (GE
healthcare) equilibrated in buﬀer A containing 100 mM NaCl. The protein was eluted with a
linear gradient from 100 mM to 500 mM NaCl (buﬀer A) over 15 CV.
Expression and puriﬁcation of Gal4-VP16 Protein expression was carried out as de-
scribed in 7.2.1 and expression was induced with 0.5 mM IPTG. Cells were lysed by sonication
in buﬀer A (10 mM Tris, pH 8.0 at 20°C; 500 mM NaCl; 10 µM ZnSO4; 10% (v/v) glycerol;
10 mM ß-mercaptoethanol), supplemented with 10 mM imidazole, 1 u/µl DNase (Fermentas)
and 1X PI. After centrifugation at 16,000xg for 20 min, the cleared lysate was applied to a
pre-equilibrated (buﬀer A) Ni-NTA agarose column (Qiagen). The column was washed with 10
CV of buﬀer B (10 mM Tris, pH 8.0 at 20°C; 100 mM NaCl; 10 µM ZnSO4; 10% (v/v) glycerol;
10 mM ß-mercaptoethanol) and 10 CV of buﬀer B containing 20 mM imidazole before elution
of the protein with buﬀer B containing 200 mM imidazole. Fractions containing Gal4-VP16
were pooled and applied to a HiTrap Q HP column (GE healthcare) equilibrated in buﬀer C
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(20 mM HEPES, pH 7.5; 10 µM Zn acetate; 10% (v/v) glycerol; 1 mM DTT). The protein
was eluted with a linear gradient from 0 mM to 700 mM NaCl in buﬀer C over 10 CV. To
remove any minor contaminants, a ﬁnal size exclusion step using a Superose 12 10/300 GL
column (GE Healthcare) in buﬀer D (20 mM HEPES, pH 7.5; 150 mM K acetate; 10 µM Zn
acetate; 10% (v/v) glycerol; 1 mM DTT) was carried out.
7.2.2 Pol II-Bye1 complex formation
Complex formation for crystallization or biochemical analysis was carried out by mixing puriﬁed
Pol II (3.5 mg/ml) with a tenfold molar excess of recombinant Bye1 and incubating the sample
ON at 4°C before further analysis.
7.2.3 Crystallization
Crystallization of the Pol II-Bye1 complex For co-crystallization of Pol II and Bye1
full-length, a stable complex was formed as described (7.2.2) before crystallization by vapour
diﬀusion with 750 mM tri-Na-citrate and 100 mM HEPES pH 7.5 as reservoir solution. Crystals
were grown for 13 days, cryo-protected in 22% glycerol, followed by one hour incubation before
harvesting and ﬂash-freezing in liquid nitrogen.
Crystallization of Pol II-EC-Bye1 TLD complex Puriﬁed Pol II (3.5 mg/ml) was mixed
with a two-fold molar excess of tailed template (7.1.6,6.3), and incubated for 1 h at 20°C before
crystallization by vapour diﬀusion with 5-7% PEG 6000, 200 mM ammonium acetate, 300 mM
sodium acetate, 50 mM HEPES pH 7.0 and 5 mM TCEP as reservoir solution. Crystals were
grown for 510 days, cryo-protected in mother solution supplemented with 22% glycerol and
containing 4 μM tailed template, followed by ON incubation at 8 °C before harvesting and
freezing in liquid nitrogen. Bye1 TLD was added to the cryo-protectant at 1 mg/ml and
crystals were incubated ON at 8°C.
Crystallization of arrested Pol II-Bye1 TLD complex Puriﬁed Pol II (3.5 mg/ml) was
mixed with a two-fold molar excess of arrest template (see 6.3 and 7.1.6), 8 mM magnesium
chloride and 2 mM CTP, and incubated for 2 h at 20 °C before crystallization by vapour
diﬀusion with 5-7% PEG 6000, 200 mM ammonium acetate, 300 mM sodium acetate, 50 mM
HEPES pH 7.0 and 5 mM TCEP as reservoir solution. Crystals were grown for 510 days, cryo-
protected in mother solution supplemented with 22% glycerol and containing 4 μM arrested
template, 2 mM CTP and 8 mM magnesium chloride, followed by ON incubation at 8°C before
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harvesting and freezing in liquid nitrogen. Bye1 TLD was added to the cryo-protectant at 1
mg/ml and crystals were incubated ON at 8°C.
Crystallization of Pol II-EC-Bye1 TLD complex containing an additional nucleotide
Crystals were prepared as described for Pol II-EC-Bye1 TLD complexes, with all cryoprotectant
solutions containing 2 mM AMPCPP.
Crystallization of Pol II-EC-SeMet Bye1 TLD complex Crystals were prepared as
described for Pol II-EC-Bye1 TLD complexes, using selenomethionine-substituted Bye1 TLD.
7.2.4 Data collection and X-ray structure determination
Diﬀraction data were collected at 100 K at beamline X06SA of the Swiss Light Source. Data
were collected at 0.91887 Å, the K-absorption peak of bromine and 0.9797 Å, the K-absorption
peak of selenium. Structures were solved with molecular replacement using BUSTER (Bricogne
et al., 2012) and the structure of 12-subunit Pol II (1WCM) as search model. Reﬁnement was
performed using iterative cycles of model building in COOT (Emsley et al., 2010) and restrained
reﬁnement in BUSTER.
7.2.5 Surface plasmon resonance
Approximately 2500 resonance units of yeast Pol II were immobilized in immobilization buﬀer
(Na-Acetate, pH 5) on the surface of a biosensor CM5 chip (Biacore) using the amine coupling
kit (Biacore) (Johnsson et al., 1991; Löfås & Johnsson, 1990). Recombinant Bye1 full-length
was injected for 60 s at 10 µl/min in running buﬀer (5 mM HEPES (pH 7.25 at 20 °C), 40
mM (NH4)2SO4, 10 µM ZnCl2, 5 mM DTT, 0.005% P20) at diﬀerent concentrations (19 nM
to 20 µM). The complex was allowed to dissociate for 5 min between injections. Aﬃnity was
measured for three independent dilution series. Raw data were corrected for the bulk signal
from buﬀer and by identical injection through a ﬂow cell in which no Pol II was immobilized.
Data were analysed with BIAevaluation software (Biacore).
7.2.6 Nuclear extract preparation
3 l yeast culture was grown in YPDS to an OD600 of 3-5 and harvested by centrifugation at 4,000
rpm for 10 min at 18°C. Pellets were resuspended in 35 ml resuspension buﬀer and incubated for
15 min at 30°C shaking in a water bath. After centrifugation at 4,000 rpm for 10 min at 18°C,
pellets were resuspended in 20 ml YPDS. For cell wall digestion and spheroplasting, 3 ml of 2 M
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Sorbitol and 3 ml resuspension buﬀer, containing 18 mg Zymolyase (Siekagaku), 1X PI and 1X
PMSF, were added and the mixture was incubated at 30°C with occasional shaking in a water
bath. Spheroplasting was monitored by measuring OD600 and was stopped when 1/10 of the
initial OD600 was reached. 100 ml YPDS were added and cells were centrifuged at 4,000 rpm for
10 min at 18°C before resuspending in 250 ml YPDS and incubation at 30°C for 30 min. Cells
were centrifuged as before, resuspended in 200 ml ice-cold YPDS, centrifuged, resuspended
in 250 ml ice-cold 1 M Sorbitol and centrifuged again. For cell membrane disruption, pellets
were resuspended in 100 ml ice-cold cell lysis buﬀer and passed three times through a pre-
chilled Dounce glass homogenizer (Kontes). Homogenized cells were then centrifuged three
times at 5,000 rpm for 8 min at 4°C and pellets were discarded. Crude nuclei were centrifuged
at 13,000 rpm for 30 min at 4°C and resuspended in 15 ml centrifugation buﬀer, washed
once by centrifugation and resuspended in 15 ml centrifugation buﬀer. For nuclear membrane
disruption, 3 M (NH4)2SO4 was added to a ﬁnal concentration of 0.5 M and incubated on a
spinning wheel at 4°C for 30 min before ultracentrifugation at 28,000 rpm for 90 min at 4°C.
To precipitate nuclear extract, 0.35 g (NH4)2SO4 was added per ml supernatant, incubated
on a spinning wheel at 4°C for 30 min and ultracentrifuged twice at 10,000 rpm for 20 min at
4°C, discarding the supernatant. To resuspend nuclear extracts, pellets were resuspended in
maximum 1.5 ml dialysis buﬀer and dialysed against 500 ml dialysis buﬀer containing 75 mM
(NH4)2SO4 for 4.5 hours. Finally, the protein concentration was determined by Bradford assay
(see 7.1.5), and 100 µl aliquots were ﬂash-frozen in liquid nitrogen and stored at -80°C.
7.2.7 In vitro transcription assay
Pol II in vitro transcription was done on the HIS4 yeast promoter inserted into pBluescript II
KS+ plasmid (6.3). The 25 µl transcription reaction contained 1X acetate transcription buﬀer,
200 µg yeast nuclear extract, 200 ng template plasmid, 192 µg phosphocreatine (Sigma), 0.2 µg
creatine phosphokinase (Sigma), 10 U RiboLock RNase inhibitor (Fermentas), 100 µM NTPs
and 150 ng recombinant Gal4-VP16 (7.2.1). The reaction was incubated for 60 min at 18°C,
followed by RNA isolation using the RNeasy MinElute kit (Qiagen). RNA was eluted with 14
µl RNase-free H2O and in vitro transcripts were subsequently analysed by primer extension.
The 20 µl primer annealing reaction contained 1X annealing buﬀer, 12 µl RNA and 0.125 pmol
ﬂuorescently labelled oligo (6.3). After boiling the sample for 3 min at 95°C, primer annealing
was carried out for 45 min at 48°C, followed by addition of 40 µl synthesis mix containing
1X synthesis buﬀer, 0.15 mM dNTPs, 12.5 U MuLV reverse transcriptase (Roche) and 1 µg
actinomycin D, and incubation for 30 min at 37°C. The resulting cDNA was EtOH precipitated
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and resuspended in 4 µl RNase A (40 µg/ml, Thermo Scientiﬁc). After incubation for 3 min
at 18°C, 4 µl formamide sample buﬀer was added and the sample boiled for 1 min. Transcripts
were separated on a urea-polyacrylamide gel in 1X TBE, scanned with a Typhoon 9400 and
quantiﬁed with the ImageQuant software (GE Healthcare).
7.2.8 RNA extension assay
For RNA extension assays, tailed templates as listed in 6.3 were used, with the diﬀerence that
the RNA was labelled with FAM at the 5' end, and the bromine in the template DNA was
replaced by a thymine. Scaﬀolds were assembled as described (7.1.6). 2.5 pmol Pol II were
incubated with 5 pmol scaﬀold for 30 min at 20°C. Additional proteins or equivalent volume
of transcription buﬀer was added and the sample was incubated in a ﬁnal volume of 6 µl ON
at 4°C. To start the reaction, 5 mM NTPs were added and the reaction was incubated for 20
min at 28°C. The reaction was stopped by adding one volume of 2X urea loading buﬀer and
incubation at 95°C for 5 min, followed by incubating samples on ice. Transcripts were separated
on a urea-polyacrylamide gel in 1X TBE, scanned with a Typhoon 9400 and quantiﬁed with
the ImageQuant software (GE Healthcare).
7.2.9 RNA cleavage assay
For RNA cleavage assays, arrest templates were used (6.3), with the diﬀerence that the RNA
was labelled with FAM at the 5' end, and the bromine in the template DNA was replaced by a
thymine. Scaﬀolds were assembled as described in 7.1.6. 2.5 pmol Pol II were incubated with
equimolar amounts of scaﬀold for 30 min at 20°C. Additional proteins or equivalent volume of
transcription buﬀer was added and the sample was incubated in a ﬁnal volume of 6 µl ON at
4°C. To start the reaction, TFIIS was added and the reaction was incubated for 20 min at 28°C.
The reaction was stopped by adding one volume of 2X urea loading buﬀer and incubation at
95°C for 5 min, followed by incubating samples on ice. Cleavage products were separated on
a urea-polyacrylamide gel in 1X TBE, scanned with a Typhoon 9400 and quantiﬁed with the
ImageQuant software (GE Healthcare).
7.2.10 Chromatin fractionation
Strains used in yeast chromatin fractionation were derived from W303. Plasmids containing
HA-tagged, full-length Bye1, Bye1 ∆PHD (∆1-177) and Bye1 ∆TLD (∆177-354) (obtained
from S.D. Hanes, (Wu et al., 2003)) were transformed into wild-type yeast. Chromatin frac-
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tionation was performed using a combination of previously described methods (Donovan et al.,
1997; Keogh et al., 2006). Cells were grown in YPD from a starting OD600 of 0.25 to mid log
phase (OD600 ~1.0). Forty OD600 units of cells were harvested by centrifugation and resuspen-
ded in 10 ml of sterile water. Following another round of centrifugation, cells were resupended
in 10 ml SB buﬀer (1 M Sorbitol, 20 mM Tris pH 7.4 at 4°C), collected by centrifugation and
stored at -80C ON. The cell pellets were then thawed on ice, resuspended in 1.5 ml PSB
buﬀer (20 mM Tris pH 7.4 at 4°C, 2 mM EDTA, 100 mM NaCl, 10 mM β-mercaptoethanol)
and transferred to a 2 ml microcentrifuge tube. Cells were allowed to mix for 10 minutes at
room temperature on a rotating shaker. Cells were pelleted by a ﬂash spin in a microcentri-
fuge and the buﬀer was aspirated. Cell pellets were washed brieﬂy in 1.5 ml SB buﬀer and
centrifuged as before. The pellet was resuspended in 1 ml SB buﬀer, and 125 µl of 10 mg/ml
Zymolyase 20T (Seikagaku Biobusiness) in SB buﬀer was added. The mixture was incubated
at room temperature for 30-60 minutes on a rotating shaker. Spheroplasting progress was
assessed by addition of 10 µl of cells to 1 ml 1% SDS and vortexing, followed by measuring
the OD600 of the liquid. Once OD600 measurement decreased by more than 80% the start-
ing value, spheroplasting was stopped with ice-cold SB buﬀer. Spheroplasts were pelleted at
2,000 rpm for 5 min at 4C. The buﬀer was removed and the pellet was gently resuspended
in 1 ml LB buﬀer (0.4 M Sorbitol, 150 mM potassium acetate, 2 mM magnesium acetate,
20 mM PIPES-KOH pH 6.8, 1 µg/ml leupeptin, 1 µg/ml pepstatin, 1 µg/ml aprotinin, 1 mM
PMSF) and pelleted as above. The LB buﬀer wash step was repeated. To lyse the cells, the
pellet was gently resupended in 250 µl LB buﬀer with 1% Triton X-100, transferred to a 1.5
ml microcentrifuge tube and incubated on ice for 10 minutes with occasional gentle mixing.
Following lysis, 125 µl was removed for the whole cell extract (WCE) and the remainder was
centrifuged at 5,000xg for 15 minutes at 4C. The supernatant was collected as the `soluble'
fraction. The `chromatin' pellet was washed once by resuspension in 125 µl of LB buﬀer with
1% Triton X-100 and spun as in the previous step. The supernatant was discarded and the
`chromatin' pellet was resuspended in 125 µl of LB buﬀer with 1% Triton X-100. All samples
were normalized to total protein content of WCE as determined by Bradford assay (7.1.5).
Normalized WCE and volume equivalents of `soluble' and `chromatin' fractions were boiled in
1X SDS loading buﬀer, separated by 15% SDS-PAGE and analysed by immunoblotting with
antibodies HA (Covance) 1:1000, H4 (Millipore) 1:1000, G6PDH (Sigma) 1:100,000.
7.2.11 Histone peptide microarrays
In general, all steps were carried out as described in Rothbart et al., 2012.
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Peptide synthesis and validation Peptides were synthesized using a PS3 peptide syn-
thesizer (Protein Technologies, Inc.) and a Symphony multiple peptide synthesizer (Protein
Technologies, Inc.). Peptide puriﬁcation was carried out by reversed-phase high-performance
liquid chromatography (RP-HPLC) and fractions were checked for the presence of the cor-
rect product by matrix-assisted laser desorption/ionization (MALDI) coupled to time-of-ﬂight
(TOF) mass spectrometry. Lyophilized peptides were stored at -80°C. Details on all peptides
used can be found in Supplemental Table 18.
Microarray fabrication For microarray printing, 100 µM stock solutions of each biotinylated
histone-peptide was prepared. 3 µl of peptide solution and 7 µl of printing buﬀer were added
to each well of a 384-well plate. Prior to printing, the plate was spun down at 500xg for 2 min.
Each peptide was spotted in triplicate eight times per array. Triplicate spots were averaged
and treated as a single value for subsequent statistical analysis.
Puriﬁcation of eﬀector protein Full-length Bye1 (residues 1-594) and Bye1 PHD (residues
47-134) were expressed as GST-fusions from exponentially growing (OD600 ~0.6) BL21 RIL
cells by ON induction with 0.4 mM IPTG at 16°C. Cells were lysed by sonication in cold 1X
PBS pH 7.6 containing 1 mM (PHD) or 5 mM (full-length) DTT, 1 mM PMSF, 1 mM ZnSO4,
and 10% glycerol (full-length only). Proteins were captured on GST-Bind Resin (Novagen) and
eluted in buﬀer containing 50 mM Tris-HCl pH 8.0 at 4°C and 10 mM glutathione. Proteins
were dialysed into buﬀer containing 20 mM Tris-HCl pH 8.0 at 4°C, 150 mM NaCl, and 1 mM
DTT prior to microarray hybridization.
Eﬀector protein hybridization and detection Prior to hybridization, microarray slides
were incubated with hybridization buﬀer for 1 h to block non-speciﬁc binding. 200 µl of
protein solution containing 1 µM of the protein of interest in hybridization buﬀer was pipetted
drop-wise on the microarray slide. After ON incubation at 4°, the microarray slide was washed
3X for 5 min with PBS, pH 7.6. Bound protein was detected by a series of antibody incubation
steps, varying depending on protein or protein-tag to be detected. Antibody incubation was
followed by washing 3X for 5 min with PBS, pH 7.6. Slides were then incubated in the dark
for 30 min with secondary antibody solution (Alexaﬂour-647) and washed again 3X for 5 min
with PBS, pH 7.6. Excess salt was washed oﬀ in 0.1X PBS, pH 7.6, and the slide was dried
by centrifugation. Detection of microarray signals was performed using the Typhoon TRIO+
imager (GE Healthcare) with a 526 nm (biotinylated ﬂuorescein) and 670 nm (secondary
antibody) emission ﬁlter.
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Data analysis Signal intensities for each spot on a scanned microarray were determined
by densitometry using the microarray analysis program ImageQuant TL (GE Healthcare) and
auto-correcting for background by subtracting the local ﬂuorescence spot edge average.
Peptides were printed as four independent subarrays, which account for subtle diﬀerences
in intensity across the slide. The eight spots per subarray for each peptide were averaged,
outliers were removed using a Grubbs test (Grubbs, 1969; Stefansky, 1972), and the average
was then treated as a single value for each subarray. The four normalized subarray values were
then used to calculate a standard deviation and standard error.
7.2.12 Chromatin immunoprecipitation analysis
Chromatin immunoprecipitation (ChIP) All strains used for chromatin immunoprecipit-
ation were TAP-tagged and are listed in Table 6.2. Strains were validated by gene-speciﬁc PCR
and westernblotting with the anti-TAP (PAP, Sigma) antibody to conﬁrm TAP-tag expression.
For chromatin immunoprecipitation, a 20 ml YPD pre-culture was inoculated with a single
yeast colony and grown ON at 30°C shaking. A 50 ml (for ChIP-qPCR)/600 ml (for ChIP-chip)
YPD-culture was inoculated with the preculture with an initial OD600 of 0.1, and grown at 30°C
shaking to an OD600 of 0.8. Cultures were incubated with 1000 ml/16.2 ml 37% formaldehyde
for crosslinking at 20°C shaking for 20 min. 5 ml/75 ml 3 M glycine were added and cultures
incubated for 5-10 min shaking at 20°C, before centrifugation for 5 min at 4,000 rpm at 4°C.
Pellets were washed once with 20 ml/100 ml ice-cold TBS, centrifuged for 5 min at 4,000
rpm at 4°C, and resuspended in 2 ml/10 ml ice-cold FA-lysis buﬀer containing 1X PI. After
centrifugation for 5 min at 4,000 rpm at 4°C, cells were resuspended in 1 ml/1.5 ml ice-cold
FA-lysis buﬀer containing 1X PI. After centrifugation for 5 min at 3,000 rpm at 4°C, pellets
were ﬂash-frozen in liquid nitrogen and stored at -80°C.
For cell lysis, pellets were thawed and resuspended in 1 ml ice-cold FA-lysis buﬀer containing
1X PI. 1 ml of cell suspension was mixed with 1 ml Zirconia beads (Biospec) and cells were
lysed in a mixer mill MM 400 (Retsch) for 30 min at 4°C. Lysis eﬃciency was monitored by
OD600 measurement. For chromatin fragmentation and resolubilisation, beads were removed
from the cell lysate by centrifugation, 200 µl ice-cold FA lysis buﬀer containing 1X PI were
added and samples were treated in a Bioruptor (diagenode) for 35 min at 4°C. Samples were
spun down at 13,000 rpm for 30 min at 4°C and chromatin concentration was determined using
a Nanodrop (7.1.5). 30 µl chromatin solution were retained as Input-control.
For immunoprecipitation, IgG Sepharose beads (Amersham) were washed once with ice-cold
TBS and three times with ice-cold FA lysis buﬀer before incubating 670 µl chromatin solution
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with 25 µl beads for 60 min on a spinning wheel at 4°C. IgG-beads were directed against the
Protein A content of the TAP-tag. Beads were spun down at 2500 rpm for 1 min at 4°C and
washed 3X with FA lysis buﬀer, twice with FA lysis buﬀer containing 500 mM NaCl, twice with
ChIP wash buﬀer and once with TE in a centrifuge-tube ﬁlter (Millipore) at 2500 rpm for 30
s at 4°C with inbetween incubation on a spinning wheel for 3 min at 4°C. To elute proteins,
beads were incubated with 120 µl ChIP elution buﬀer for 10 min at 65°C shaking, followed
by centrifugation twice for 1 min at 13,000 rpm at RT. To reverse the crosslinks, 80 µl TE
and 20 µl Proteinase K (20 mg/ml, ) were added to the IP sample, and 100 µl ChIP elution
buﬀer, 60 µl TE and 20 µl Proteinase K were added to the Input sample. Both samples were
incubated for 2 h at 37°C, followed by ON incubation at 65°C in a thermocycler (Biometra
T3000 Thermocycler). DNA was puriﬁed using the QIAquick PCR puriﬁcation kit (Qiagen)
and eluted in 50 µl DNase-free H2O.
Quantitative real-time PCR (qPCR) For ChIP experiments, input and immunoprecipit-
ated samples (see 7.2.12) were assayed by qPCR to determine protein occupancies at diﬀerent
genomic regions.
Primers for qPCR reactions were 18-24 nt long and were designed with the OligoPerfect
Designer (Invitrogen). qPCR products were 60-70 nt long and PCR eﬃciency was validated
using diﬀerent concentrations of DNA template and determining PCR eﬃciency using the
BioRad CFX Manager software. Only primer pairs with an eﬃciency ≥90% were used in
ChIP-qPCR experiments.
A 24 µl master mix was prepared, containing 2 µl of 10 µM primer pairs and 12.5 µl iTaq
SYBR Green Supermix (BioRad). 1 µl of DNA was added and all reactions were carried out
in 96-well plates. qPCR was performed on a BioRad CFX96 Real-Time System using a 3 min
denaturing step at 95°C, followed by 40 cycles of 30 s at 95°C, 30 s at 61°C and 15 s at
72°C. Threshold cycle (Ct) values were determined using the BioRad CFX Manager software
setting regression. The IP eﬃciency and fold enrichment of any given region over control
regions (ORF-free heterochromatic region on chromosome V) was determined as described in
Fan et al. (2008).
Tiling-array hybridization DNA samples puriﬁed as described in 7.2.12 were ampliﬁed
with GenomexPlex Complete Whole Genome Ampliﬁcation 2 (WGA2) Kit using the Farnham
Lab WHA Protocol for ChIP-chip (O'Geen et al., 2006). Brieﬂy, 10 µl of concentrated ChIP
DNA was used to generate the PCR-ampliﬁable OmniPlex Library, consisting of ChIP DNA
molecules ﬂanked by universal priming sites. Library preparation was performed as described in
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the WGA2 Kit (Sigma). The OmniPlex Library was then ampliﬁed by PCR and puriﬁed using
the QIAquick PCR puriﬁcation kit (Qiagen). DNA was eluted with 50 µl H2O and quantity and
quality was determined with a Nanodrop and agarose gel electrophoresis. Puriﬁed DNA was
re-ampliﬁed in the presence of 0.4 mM dUTP, which is required for enzymatic fragmentation
of DNA.
DNA fragmentation, labelling, hybridization and array scanning were performed according
to manufacturer's instructions (AﬀymetriX Chromatin Immunoprecipitation Assay Protocol
P/N 702238). At least two independent biological replicates were analysed for each factor.
Bioinformatic analysis All data normalization procedures were performed using R (R Devel-
opment Core Team, 2008) and Bioconductor (Gentleman et al., 2004). For data import of the
AﬀymetriX CEL ﬁles and the conversion into the basic Bioconductor object class for microarray
data Expression Set, we used the R package Starr (Zacher et al., 2010). Data normalization
consisted of three steps: First, quantile normalization between replicate measurements was
carried out. Second, the signal for each probe was averaged by calculating the geometric
average over the replicate intensities. Third, data from all factors were normalized using a
combined mock IP (untagged WT strains) plus input reference normalization. Additional as-
pects of data normalization were described in (Mayer et al., 2010). Normalized signals were
converted to occupancy values between 0-100% by setting the genome-wide 99.8% quantile
to 100% occupancy and the 10% quantile to 0% occupancy.
For gene-averaged occupancy proﬁles, Saccharomyces cerevisiae genes with available TSS
and pA assignments from RNA-seq experiments (Nagalakshmi et al., 2008) were grouped into
four ORF length classes: extremely short (XS) ranging from 256-511 bp (93 genes), short (S)
for 512-937 bp(266 genes), medium (M) for 938-1537 bp (339 genes), and long (L) for 1538
to 2895 bp (299 genes). Only genes containing a TSS-ATG distance ≤ 200 bp, a minimal ORF
and transcript distance to ﬂanking genes of 250 bp and 200 bp, respectively, and genes being
grouped into the 50% highest expressed nuclear protein-coding genes (Dengl et al., 2009) were
included in the analysis. Proﬁles within these groups were scaled to median gene length, and
gene-averaged proﬁles were calculated by taking the median over gene factor proﬁles.
7.2.13 Synthetic lethality screen
Strain BY5563 bye1 ∆ (see 6.2) was generated as described in 7.1.1 and 7.1.2 by replacing the
bye1 ORF with the ClonNAT ORF, which confers resistance to the antibiotic nourseothricin. In
addition, the strain contains a MFA1pr-HIS3 reporter, which allows for selective germination for
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MATa meiotic progeny after sporulation. The strain was crossed to an ordered array of viable
yeast deletion mutants (Giaever et al., 2002), each carrying a gene deletion mutation linked to a
kanamycin-resistance marker (kanMX). Resulting heterozygous diploids were selected on GNA
medium, containing 100 µg/ml nourseothricin and 200 µg/ml kanamycin. The heterozygous
diploids were transferred to sporulation medium to induce the formation of haploid meiotic
spore progeny. Spores were then transferred to media lacking histidine (SD-H) to select for
MATa meiotic progeny before selecting for double-mutant meiotic progeny in GNA medium
containing both 100 µg/ml nourseothricin and 200 µg/ml kanamycin. Growth of double-
mutants was then monitored by visual inspection for 48 h. The screen was performed on a
Beckman-Coulter Biomek FX.
Strains used to validate candidates from the synthetic lethality screens (6.2) were derived
from BY4741 and generated as described in 7.1.1 and 7.1.2.
7.2.14 Non-homologous end-joining (NHEJ) assay
To assay NHEJ eﬃciency, the pRS314 vector was linearized by restriction digest with EcoRI
as described in 7.1.2 and transformed into yeast cells as described in 7.1.1. As the EcoRI
restriction site is located within the ura3 gene, circularization of the linearised vector by NHEJ
is required for cells to allow growth on plates lacking uracil. Transformed WT and mutant cells
were plated on -ura plates and incubated for 3 days at 30°C. Colonies were counted to monitor
NHEJ eﬃciency. To normalize for transformation eﬃciency, the circularized pRS314 vector
was transformed, and cells treated and colonies counted as described. Three independent
experiments were carried out for each yeast strain.
7.2.15 Fluorescence-activated cell sorting (FACS)
Cells were grown in 50 ml YPD at 30°C at 160 rpm from a starting OD600 of 0.1 until an
OD600 of 0.4 was reached. Before synchronization by addition of α-factor (10 µg/ml ﬁnal
concentration), 1 ml was taken as unsynchronized control and stored at 4°C after addition of
2.5 ml 100% EtOH. Cells were synchronized at 30°C at 160 rpm and checked inbetween for
shmoo formation by light microscopy. When shmoo formation was completed (about 2 h),
cells were spun down for 2 min at 1600 x g at 30°C, washed with 200 ml pre-warmed YPD,
spun down again, resuspended in 50 ml pre-warmed YPD and incubated at 30°C at 160 rpm.
1 ml samples for FACS analysis were taken every 10 min for 120 min and stored at 4°C after
addition of 2.5 ml 100% EtOH.
Samples were spun down for 3 min, washed once with 1 ml 50 mM Na citrate (pH 7.0),
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resuspended in 100 µl 50 mM Na citrate (pH 7.0) containing RNase A (0.1 mg/ml, Fermentas),
and incubated ON at 37°C with slight shaking. 1 mg/ml Proteinase K (Thermo Scientiﬁc)
was added and samples were incubated for 2 h at 50°C with slight shaking. Samples were
washed once with 50 mM Na citrate (pH 7.0) and samples were adjusted to approximately
106 cells/ml. Cells were resuspended in 1 ml 50 mM Na citrate (pH 7.0) containing 1 µM
Sytox Green (Invitrogen). After separation of doublets in a bioruptor (6x 10 s, with 10 s pause
inbetween), 100 µl cells were added to 900 µl Sytox Green mix and transferred to FACS tubes
for analysis on FACS Calibur ﬂow cytometer (BD).
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Part III
Results and Discussion
8 Structures of RNA polymerase II complexes with
Bye1, a chromatin-binding PHF3/DIDO homologue
Data presented in this chapter have been obtained during this thesis and have been published
(see page viii).
8.1 Bye1 interacts with Pol II
To test whether Pol II binds directly to Bye1 in vitro, we incubated pure yeast Pol II with
recombinant Bye1 (see 7.2.2) and subjected the sample to size-exclusion chromatography. A
stable and apparently stoichiometric Pol II-Bye1 complex was obtained (Fig. 8A). To charac-
terize the Pol II-Bye1 interaction, we used surface plasmon resonance. We immobilized Pol II
on a Biacore sensor chip (Löfås & Johnsson, 1990; Johnsson et al., 1991) and determined Bye1
association and dissociation rates. The ratio of these rates provided a dissociation constant of
KD=3.8 ± 2.2 µM (Fig. 8B,C).
Figure 8: Analysis of the Pol II-Bye1 interaction.
(A) SDS-PAGE analysis (Coomassie staining) of endogenous yeast Pol II (left), recombinant Bye1 (centre), and the Pol II-Bye1
complex after size exclusion chromatography (right) (B) Time-resolved binding of Bye1 dilution series. For reasons of clarity, only
one representative curve is shown for each measurement. All measurements have been carried out in triplicates. (C) Corresponding
ﬁtted curve (solid line). The curve is reference and blank subtracted.
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8.2 Structure of Bye1-bound Pol II elongation complex
Co-crystallisation of Pol II with full-length Bye1 yielded crystals diﬀracting to 4.8 Å resolution
(Table 16). Structure solution by molecular replacement with free Pol II (Armache et al., 2005)
revealed positive diﬀerence density for the Bye1 TLD on the Rpb1 surface, but no density for
the two other Bye1 domains. To obtain better diﬀraction, the Bye1 TLD was expressed in
isolation and soaked into preformed Pol II elongation complex crystals containing a DNA-RNA
scaﬀold. Diﬀraction data to 3.15 Å resolution were obtained (Table 16). Phasing with the
Pol II structure (Armache et al., 2005) revealed positive diﬀerence density at the same location
observed with full-length Bye1 (Fig. 9A, B).
Figure 9: Structure of the Pol II-Bye1 elongation complex.
(A) Ribbon model of the Pol II-Bye1 elongation complex crystal structure. The views correspond to the side and front views of
Pol II (Cramer et al., 2001) and are related by a 90° rotation around a vertical axis. (B) Sigma-A weighted diﬀerence electron
density (blue mesh, contoured at 2.58σ) for the Bye1 TLD (green). (C) Close-up view of the Pol II-Bye1 interaction. Mobile
loops are indicated by dashed lines.
The Bye1 TLD structure was built with the aid of sequence markers obtained with seleno-
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methionine-labelled protein, and the complex structure was reﬁned to a free R-factor of 21.19%
(Table 16).
8.3 Bye1 binds the polymerase jaw
The Bye1 TLD fold comprises an N-terminal three-helix bundle (helices α1-α3) followed by
two short helices (α4, α5) that link to an extended C-terminal helix α6 (Fig. 9C). This fold
resembles that of TFIIS domain II (helices α1-α5) (Kettenberger et al., 2003), and helix α6
corresponds to the linker between TFIIS domains II and III (Fig. 10A). The Bye1 TLD binds
the Rpb1 jaw domain at the location where TFIIS domain II binds the polymerase (Fig. 10B).
Despite this overall similarity, the Pol II contacts by the Bye1 TLD and TFIIS diﬀer. The Bye1
helix α3 binds loop ß30-ß31 and helix α40 of the Rpb1 jaw domain and induces ordering of
loop α40-ß29. Helix α6 extends from the jaw into the Pol II funnel, contacting the Rpb1 loops
α20-α21 and ß29-α41, and strand ß32 of the Rpb1 funnel domain. The Bye1 loop α2-α3
contacts the N-terminus of Rpb5 (Fig. 10C-E).
Table 16: Diﬀraction data and reﬁnement statistics
Pol II-Bye1 FL Pol II-Bye1 TLD Pol II-Bye1 TLD
+ AMPCPP
Arrested
Pol II-Bye1 TLD
pdb code 4bxz 4by7 4by1 4bxx
Data collection
Space group C2221 C2221 C2221 C2221
Unit cell (Å) 220.55
392.09
279.80
222.50
390.68
281.97
222.24
391.58
281.02
222.92
392.67
281.04
Unit cell angle (°) α=β=γ=90° α=β=γ=90° α=β=γ=90° α=β=γ=90°
Resolution range (Å) 49.63-4.80
(4.92-4.80)
48.84-3.15
(3.23-3.15)
48.95-3.60
(3.69-3.60)
49.08-3.28
(3.37-3.28)
Unique reﬂections 59394 (4352) 210346 (15471) 141065 (10391) 187168 (13766)
Completeness (%) 99.97 (100) 99.98 (100) 99.98 (100) 99.98 (99.98)
Redundancy 7.50 (7.82) 7.66 (7.74) 7.62 (7.61) 7.66 (7.49)
Rsym (%) 40.9 (173.0) 11.6 (165.2) 21.2 (193.4) 12.9 (185.4)
I/σ(I) 6.05 (1.24) 15.97 (1.60) 9.95 (1.57) 14.66 (1.52)
CC(1/2) 98.5 (60.8) 99.8 (63.2) 99.6 (56.3) 99.8 (67.1)
Reﬁnement
Non-H atoms 31510 33261 33026 32753
B-factor (mean, Å²) 199.00 115.07 125.08 120.50
Rmsd bonds 0.010 0.010 0.009 0.010
Rmsd angles 1.33 1.22 1.21 1.29
Rcryst (%) 19.06 18.94 17.49 17.98
Rfree (%) 25.27 21.19 20.62 20.77
Values in parenthesis are for the highest resolution shell. All data were collected with a radiation wavelength of 0.9188 Å.
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Figure 10: Pol II-Bye1 interaction and comparison with TFIIS.
(A) Side view of the Bye1 TLD bound to Pol II (top), TFIIS in its Pol II-bound state (middle, Cheung & Cramer (2011)) with its
central domain II (green), linker helix (yellow) and the C-terminal zinc ribbon domain III (orange), and superposition of the two
structures (bottom). (B) Ribbon model of the Pol II-TFIIS complex (Cheung & Cramer, 2011). (C) Details of the interaction of
the Bye1 TLD with the Pol II Rpb1 jaw domain (blue) shown in side view. Residues involved in hydrogen bond formation or salt
bridges (dashed lines) are shown as sticks. (D) Details of the interaction of the Bye1 TLD with the Pol II Rpb1 funnel and jaw
domain shown in side view. (E) Details of the interaction of the Bye1 TLD with the Pol II Rpb5 jaw domain (magenta) shown in
side view.
8.4 Bye1 does not change Pol II conformation
TFIIS binding to Pol II induces three major conformational changes in the polymerase elongation
complex. It repositions the jaw-lobe module, traps the trigger loop in a locked conformation
(Kettenberger et al., 2003), and realigns the RNA in the active site (Kettenberger et al., 2004).
Although Bye1 resembles part of TFIIS and binds to a similar position on Pol II, it does not
induce conformational changes (Fig. 11A). This lack of conformational changes was observed
in structures of Pol II complexes with the Bye1 TLD, but also with full-length Bye1.
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Figure 11: Bye1 does not inﬂuence Pol II conformation.
(A) In the Pol II-TFIIS complex structure, conformational changes in Pol II are induced by movements of the Pol II Rpb1 loop
α20-α21, which results in opening of a crevice in the polymerase funnel. Loop movements are observed for TFIIS-bound Pol II
(yellow, Cheung & Cramer, 2011), but not for Bye1-bound (green, this study) or unbound (silver, Kettenberger et al., 2004) Pol
II. (B) Contacts of AMPCPP with the closed trigger loop in the AMPCPP-containing Pol II-Bye1 elongation complex structure.
Residues involved in hydrogend bond formation are shown as sticks, hydrogen bonds are indicated by dashed lines. A few residues
of the trigger loop that face away from the AMPCPP are mobile (dashed line). (C) Ribbon model of the Pol II-Bye1 complex
containing an additional nucleotide. (D) Ribbon model of the arrested Pol II-Bye1 complex.
Results and Discussion
These observations predicted that Bye1 does not impair nucleoside triphosphate (NTP)
binding to Pol II, which requires closure of the trigger loop. Indeed, we were able to show
closure of the trigger loop and binding of an NTP substrate analogon in the presence of Bye1
by crystallizing an additional complex of Bye1 TLD bound to the Pol II elongation complex
with AMPCPP (Fig. 11B,C and Table 16). Furthermore, Bye1 TLD binding also did not
prevent backtracking of RNA into the Pol II pore, as seen in another structure of Bye1 bound
to arrested Pol II with backtracked RNA (Fig. 11D and Table 16).
8.5 Bye1 does not inﬂuence basic Pol II functions
These observations suggested that Bye1 had no functional inﬂuence on basal transcription.
Indeed nuclear extracts prepared from yeast cells lacking the gene encoding Bye1 were active in
promoter-dependent in vitro transcription assays, and addition of puriﬁed Bye1 to WT nuclear
extracts did not alter their activity (Fig. 12A). In contrast to TFIIS, Bye1 did not induce
Pol II backtracking and RNA cleavage on DNA-RNA scaﬀolds, but allowed for unperturbed
elongation activity in RNA extension assays (Fig. 12B,C). Collectively these data indicate
that Bye1 neither induces structural changes in Pol II functional complexes nor inﬂuences their
function in vitro.
Figure 12: Bye1 does not inﬂuence basic Pol II functions.
(A) Transcriptional activity of wildtype (WT) and Bye1-depleted (bye14) nuclear extracts (NE) in an in vitro transcription assay
using nucleosome-free DNA template. (B) Nucleic acid scaﬀold for reconstitution of Pol II-EC. (C) Electrophoretic separation of
RNA products obtained in RNA extension assays.
8.6 Bye1 associates with chromatin via its TLD domain
The above results suggested that Bye1 functions in a chromatin context. To investigate
whether Bye1 associates with chromatin in vivo and whether its Pol II-binding TLD is required
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for this, we biochemically separated cell extracts into an insoluble fraction, containing chromatin
and associated proteins, and a soluble fraction, containing free proteins in the cytoplasm and
nucleoplasm. We used strains harbouring plasmids containing HA-tagged full-length Bye1
(WT) or variants lacking either the PHD domain (∆PHD) or the TLD domain (∆TLD) (Wu
et al., 2003). All variants of Bye1 were present at the same level in unfractionated whole
cell extract (Fig. 13, lanes 1-4). Wild-type Bye1 and its ∆PHD variant were present in the
chromatin and soluble fractions, but the ∆TLD variant associated with chromatin only very
weakly (Fig. 13, lanes 9-12). These results demonstrate that a fraction of the Bye1 protein
present in cells associates with chromatin, and that the TLD of Bye1 is important for the
association.
Figure 13: Bye1 associates with chromatin via its TLD.
Immunoblot of whole-cell extract (WCE), soluble and chromatin-bound cell fraction to hemagglutinin tag (HA), histone 4 (H4)
and glucose-6-phosphate-1-dehydrogenase (G6PDH). For details compare text.
8.7 Bye1 binds active histone marks via its PHD domain
In addition to the observations described above, it has been reported that the Bye1 PHD
domain contributes to chromatin association by binding trimethylated H3K4 peptides (Shi
et al., 2007). We therefore investigated binding of the Bye1 PHD domain to roughly 200
diﬀerentially modiﬁed histone peptides on a microarray (Rothbart et al., 2012). Microarrays
were spotted at high density (~4,000 individual features) with histone peptides that encompass
known single and combinatorial PTMs on the core and tail domains of the four histone proteins
H3, H4, H2A, and H2B, and their variants (see Supplemental Table 18). The Bye1 PHD
domain as well as full-length Bye1 bound speciﬁcally to H3K4me3 peptides (Fig. 14A). The
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high correlation between arrays probed with full length Bye1 and the isolated PHD domain
indicated that the histone binding potential of Bye1 is harboured within its PHD domain (Fig.
14B).
Figure 14: Bye1 preferentially binds histone peptides carrying PTMs of active transcription.
(A) Peptide array binding analysis reveals that Bye1 preferentially associates with H3K4me3 peptides, and its PHD domain is
suﬃcient for this interaction. Results of two independent arrays consisting of 24 individual spots for each peptide are presented as
relative mean intensity measurements on a scale from 0 to 1, with 1 being the most signiﬁcant peptide interaction. (B) Scatter
plot correlating relative mean intensity measurements of all peptide interactions from arrays probed with full-length Bye1 and the
Bye1 PHD domain. H3K4me3-containing peptides are shown as green dots. All other peptides on the array are shown as black
dots. The correlation coeﬃcient was calculated by linear regression analysis using GraphPad Prims v5. (C) Heat map depicting
the eﬀects of combinatorial PTMs on the binding of Bye1 to H3K4me3-containing peptides. Average binding intensities are
represented relative to the H3K4me3 peptide (0, white). Enhanced (>0, blue) and perturbed (<0, red) interactions are depicted.
(D) Summary of modiﬁcations enhancing (blue) and perturbing (red) the Bye1 interaction with H3K4me3 peptides.
The interaction of Bye1 with H3K4me3 was strongly inﬂuenced by neighbouring PTMs (Fig.
14C). In particular, marks of active transcription (H3K9ac, H3K14ac, H3K18ac, and H3S10p
(Oliver & Denu, 2011; Nakanishi et al., 2008; Kurdistani & Grunstein, 2003)) enhanced Bye1
aﬃnity to H3K4me3, whereas marks of transcriptional repression (H3R2 and H3R8 methylation,
Cit2, T3 and T6 phosphorylation, and H3K9me3 (Oliver & Denu, 2011; Pal et al., 2004, 2007;
Chen et al., 1999)) perturbed the interaction with H3K4me3 (Fig. 14D).
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8.8 Bye1 occupies the 5'-region of active genes
To test whether Bye1 is recruited to actively transcribed genes in vivo, we carried out gen-
omic occupancy proﬁling with the use of chromatin immunoprecipitation (ChIP) as described
(7.2.12).
Figure 15: Bye1 occupies the 5' region of active genes.
(A) Gene-averaged Bye1 ChIP occupancy proﬁle for the median length class (1238±300 nt, 339 genes). TSS, transcription start
site; pA, polyadenylation site. (B) Correlation of Bye1 and Spt5 occupancies. (C) Comparison of Bye1 and H3K4me3 (Schulze
et al., 2011) occupancy proﬁles.
Metagene analysis by averaging occupancy proﬁles of genes of similar length revealed a
Bye1 occupancy peak 110 nucleotides downstream of the transcription start site (TSS) (Fig.
15A). No signiﬁcant signals were observed in promoter regions and at the polyadenylation (pA)
site. Bye1 was found on all active genes and its occupancy level correlated with those for bona
ﬁde Pol II elongation factors such as Spt5 (Fig. 15B). Published ChIP data for H3K4me3 shows
a peak at a similar location downstream of the TSS, although the peak is broader (Fig. 15C,
Schulze et al., 2011). These results indicated that Bye1 is recruited to the 5'-region of active
genes in vivo, and suggest that H3K4me3 contributes to Bye1 recruitment. In order to interpret
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the ChIP data, we generated a three-dimensional topological model of the Bye1-bound Pol II
elongation complex approaching the +2 nucleosome of an active yeast gene (Fig. 16B).
Figure 16: Bye1 can interact simultaneously with Pol II and H3K4me3.
(A) Scheme showing occupancies of Bye1 and H3K4me3 (Schulze et al., 2011) derived from ChIP data and nucleosome position
derived from microarray and high-throughput DNA sequencing data (Jiang & Pugh, 2009). (B) Model of a Pol II-nucleosome-Bye1
complex based on crystal structures and ChIP occupancy peak positions. Distances in base pairs (bp) are indicated between the
Pol II active centre and the nucleosome as well as for the nucleosomal DNA. The model is based on the structure of the nucleosome
core particle (1aoi) by Luger et al. (1997). Modelling was performed with Coot (Emsley et al., 2010). Bye1 PHD and SPOC
domains were modelled using Modeller (Sánchez & Sali, 1997). The PHD domain model is based on structures 3kqi, 1wem, 1wew,
2lv9 and 1wep, which were identiﬁed by HHpred (Söding et al., 2005) to be most similar to Bye1 PHD. Binding of the PHD
domain to H3K4me3 was modelled based on structure 2jmj. The SPOC domain model is based on structure 1ow1.
For the modelling we assumed that Bye1 crosslinks to DNA via Pol II in ChIP experiments,
and set the Pol II active centre to nucleotide position +110 downstream of the TSS. We
positioned the +2 nucleosome based on its experimentally deﬁned average position (Jiang
& Pugh, 2009) (Fig. 16A). We also included models of the ﬂexible Bye1 SPOC and PHD
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domains, with the latter positioned on the H3 tail emerging from the core nucleosome particle
(Fig. 16B). Although the trajectory of the H3 tail is unclear, and although the linkers between
the Bye1 domains are ﬂexible, the resulting model explained the position of the ChIP peak with
high H3K4me3 occupancy. The model also suggests that it is structurally possible for Bye1 to
interact simultaneously with the Pol II core and the trimethylated H3 tail in the 5' region of
active genes.
8.9 Bye1 genetically interacts with Paf1 and Tho2
In order to identify genes that interact functionally with the gene encoding Bye1 and thereby
further elucidate Bye1 function, we screened a yeast deletion strain collection (Tong et al., 2001,
2004) for synthetic growth defects with bye1∆, which does not show any obvious phenotype
(Wu et al., 2003). This screen revealed two candidate genes, paf1 and tho2. Generating
bye1∆paf1∆ and bye1∆tho2∆ double mutants in a diﬀerent genetic background conﬁrmed
the synthetic interaction between these genes (Fig. 17).
Figure 17: Bye1 genetically interacts with Paf1 and Tho2.
Serial dilutions of strains bye14, paf14, bye14paf14, tho24, bye14tho24, and an isogenic wild-type (WT) control strain
were placed on YPD plates and incubated at 30°C for 3 days.
The genes paf1 and tho2 encode for subunits of two bona ﬁde elongation factor complexes.
Paf1 belongs to the 5-subunit Paf complex that recruits the histone methyltransferase Set1 to
transcribed genes (Jaehning, 2010; Krogan et al., 2003; Wood et al., 2003; Shilatifard, 2008;
Dehé & Géli, 2006). Set1 in turn is responsible for H3K4 trimethylation during transcription
(Roguev et al., 2001). The PHD interaction of Bye1 with H3K4me3 is therefore a plausible
link between Paf1 and Bye1. Tho2 resides in the 4-subunit THO complex that is required
for eﬃcient transcription elongation (Rondón et al., 2003). These results therefore strongly
support an involvement of Bye1 in transcription elongation through chromatin.
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8.10 PHF3 and DIDO are human homologues of Bye1
No homologues in higher eukaryotes have been reported for Bye1. We performed a bioinform-
atics search based on the Pfam database (Punta et al., 2012) to identify potential homologues
with the same domain organization. We found two human proteins, PHD ﬁnger protein 3
(PHF3) and Death-inducer obliterator (DIDO), which show the same domain organization as
Bye1 (Fig. 18). Both proteins contain an N-terminal PHD domain, a central TLD domain,
and a C-terminal SPOC domain, with linkers of varying lengths in between these domains.
Homology for both proteins could not be inferred based on sequence homology (E-value: 2e-04
(PHF3)/ 5e-04 (DIDO)). PHF3 has been associated with glioma development as its expression
is signiﬁcantly reduced or lost in glioblastomas (Fischer et al., 2001). DIDO is a potential
tumor suppressor showing abnormal expression patterns in patients with myelodysplastic and
myeloproliferative diseases (Fütterer et al., 2005). Speciﬁc binding of the DIDO PHD domain
to H3K4me3 has been reported recently (Gatchalian et al., 2013).
Figure 18: Domain organization of Saccharomyces cerevisiae (Sc) Bye1, Homo sapiens (Hs) PHF3 and Homo sapiens (Hs) DIDO.
PHD: Plant Homeodomain, TLD: TFIIS-like domain, SPOC: Spen paralogue and orthologue C-terminal domain. Bordering residue
numbers are indicated.
To corroborate the homology of PHF3 and DIDO with Bye1, we analysed the conservation
of the Pol II-TLD interface. Both yeast Pol II and Bye1 TLD surfaces forming the interface
are well conserved in human Pol II and PHF3/DIDO, respectively (Fig. 19A, B). In particular,
a salt bridge between yeast Bye1 residue K314 and E1168 in the largest Pol II subunit Rpb1
is conserved in the predicted human PHF3/DIDO-Pol II complexes. Similarly, many hydrogen
bonds observed between the Bye1 TLD and Rpb1 (Bye1 residues N292, S311, D315, R355,
N362, F363) are predicted to be conserved in the homologous human complexes. These
results indicate that PHF3 and DIDO contain Pol II-binding TLD domains and are human
homologues of Bye1, and our structural, biochemical and genetic results provide a starting
point for elucidating the function of these proteins.
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Figure 19: PHF3 and DIDO are human homologues of Bye1.
(A) Amino-acid sequence alignments of S.cerevisiae Bye1, H.sapiens PHF3, H.sapiens DIDO, H.sapiens TFIIS and S.cerevisiae
TFIIS. Secondary structure elements are indicated as arrows (ß strands) or rods (helices). Loops are indicated with solid lines.
Residues that are part of the Pol II-Bye1 interface are marked with black triangles. Residues essential for the Pol II-TFIIS interaction
(Awrey et al., 1998) are marked with black asterisks. (B) Amino-acid sequence alignments of S.cerevisiae Rpb1 and H.sapiens
Rpb1. Residues that are part of the Pol II-Bye1 interface are marked with black triangles.
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9 Further analysis of Bye1 function
Data presented in this chapter have been obtained during this thesis, but have not been
published.
9.1 Bye1 genetically interacts with Fyv6
In addition to a genetic interaction of bye1 with paf1 and tho2 (see 8.9), we identiﬁed in the
same screen a genetic interaction between bye1 and fyv6. Generating bye1∆fyv6∆ double
mutants in a diﬀerent genetic background conﬁrmed the synthetic interaction between these
genes (Fig. 20A). We also tested for genetic interactions between TFIIS (encoded by the gene
dst1) and genes interacting with Bye1, but could not observe growth defects. (Fig. 20B)
Figure 20: Bye1 genetically interacts with Fyv6.
(A) Serial dilutions of strains bye14, fyv64, bye14fyv64, and an isogenic wild-type (WT) control strain were placed on YPD
plates and incubated at 30°C for 3 days. (B) Serial dilutions of strains dst14, fyv64, dst14fyv64, tho24, dst14tho24,
paf14, dst14paf14,and an isogenic wild-type (WT) control strain were placed on YPD plates and incubated at 30°C for 3
days. (C) Relative NHEJ eﬃciency of fyv6∆ mutants compared to WT cells. Cells were transformed with a linearized vector,
and circularization thereof allowed cells to grow on selective plates. Colonies on selective plates were counted to monitor NHEJ
eﬃciency. For details, see 7.2.14.
Based on genome wide screens (Wilson 2002), Fyv6 has been proposed to regulate double-
strand break (DSB) repair via non-homologous end-joining (NHEJ). To elucidate this function
further, we determined the NHEJ eﬃciency of fyv6∆ mutants as described in 7.2.14. As fyv6∆
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mutants did not show any obvious defect in NHEJ (Fig. 20C), the function of Fyv6 and a
possible functional link to Bye1 need to be elucidated further.
As Bye1 has been suggested to negatively regulate transcription elongation (Wu et al.,
2003), we wanted to investigate this function further in the context of the above described
genetic interactions. For this, we screened mutants for their sensitivity to 6-azauracil (6-AU)
and mycophenolic acid (MPA). Both 6-AU and MPA lead to a reduction of ribonucleotide
levels by inhibiting IMP dehydrogenase (Riles et al., 2004). Therefore, resistance to both 6-AU
and MPA depends on fully functional transcription elongation factors for eﬃcient transcription
(Archambault et al., 1992). As can be seen in Fig. 21, fyv6∆ mutants showed increased
sensitivity to 6-AU, and this sensitivity could be partially rescued by bye1∆. No sensitivity to
MPA could be observed, and bye1∆tho2∆ and bye1∆paf1∆ mutants showed no increased
sensitivity to either 6-AU or MPA. These ﬁndings suggest that Fyv6 function is linked to
transcriptional processes, and that Bye1 counteracts this function.
Figure 21: Sensitivity of mutants to 6-AU and MPA.
Serial dilutions of strains bye14, fyv64, bye14fyv64, tho24, bye14tho24, paf14, bye14paf14,and an isogenic wild-type
(WT) control strain were placed on minimal media plates lacking uracil (-ura) and containing indicated amounts of (A) 6-AU and
(B) MPA, and were incubated at 30°C for 3 days.
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9.2 Recruitment of Paf1, Tho2, and Pol II is not aﬀected in bye1∆
mutants
Based on the observed genetic interactions (8.9 and 9.1), we next asked whether Bye1 is re-
quired for recruitment of Paf1, Tho2 and Pol II (Rpb3) to active genes. For this, we performed
chromatin immunoprecipitation in WT cells as well as bye1∆ mutants and determined occu-
pancy levels on two housekeeping genes, ADH1 and PMA1 (for details, see 7.2.12 and 7.2.12).
Both Paf1 and Pol II (Rpb3) showed similar occupancy levels in WT and mutant backgrounds
(Fig. 22A, B), indicating that Bye1 is not directly required for their recruitment. Similar results
were observed for Tho2 (Fig. 22C), however, occupancy levels were very low and therefore do
not allow for detailed interpretation.
Figure 22: Recruitment of Pol II (Rpb3), Paf1 and Tho2 in WT cells and bye1∆mutants.
ChIP-analysis reveals that recruitment of (A) Pol II (Rpb3), (B) Paf1 and (C) Tho2 is not aﬀected in bye1∆ mutants (grey)
compared to WT cells (black). (D) Occupancy of Fyv6 on housekeeping genes is low and does not show a distinct pattern. The
fold enrichments at the ADH1 and PMA1 gene over a non-transcribed region that is located near the centromere of chromosome
V are given for the 5' UTR, the ORF region and the 3' UTR. The standard deviations are for two independent ChIP experiments.
As Fyv6 function seemed to be linked to transcriptional processes (see 9.1), we also determ-
ined occupancy levels of Fyv6 on housekeeping genes. As shown in Fig. 22D, Fyv6 occupancy
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is low on housekeeping genes and does not show a distinct pattern, conﬁrming our previous
ﬁndings that Fyv6 function is only indirectly linked to transcriptional processes.
9.3 Bye1 is genetically linked to replication fork stalling
To further investigate genetic interactions, above described strains were tested for their sen-
sitivity to DNA damaging agents such as hydroxyurea (HU), Phleomycin, Etoposide and methyl-
methanesulfonate (MMS) (Fig. 23, and Table 17). HU as well as MMS treatment results in
replication fork stalling (Snyder, 1984; Tyrsted, 1982; Slater, 1973; Nickoloﬀ et al., 1998; Ter-
cero & Diey, 2001), which eventually results in DSBs. Phleomycin treatment results in SSBs
as well as DSBs by intercalation into the DNA helix (He et al., 1996). Etoposide in turn inhibits
Topoisomerase II, thereby inducing exclusively double strand breaks (Hande, 1998).
Double knockout mutants (bye1∆fyv6∆, bye1∆tho2∆ and bye1∆paf1∆) showed in-
creased sensitivity to Phleomycin, whereas no sensitivity could be observed for single knockout
mutants (bye1∆, fyv6∆, tho2∆, paf1∆ ). As none of the mutants showed increased sensit-
ivity to Etoposide, the observed phenotypes suggest that increased sensitivities are a) a direct
eﬀect of the Bye1 knockout and b) possibly due to single strand breaks. In addition, increased
sensitivity of fyv6∆ mutants to HU could be observed, and this phenotype was rescued by
bye1∆. Taken together, these ﬁndings indicate involvement of Bye1 in HU induced replication
fork stalling, or rescue thereof.
One mechanism linking transcription and replication fork stalling is formation of R-loops.
R-loops are three-strand nucleic acid structures formed by an RNA:DNA hybrid plus a displaced
DNA strand identical to the RNA molecule. The nascent RNA transcript invades the DNA
duplex as soon as it exits Pol II during backtracking. Formation of R-loops during transcription
has  among other incidents  been observed when replication and transcription machineries
collide (Bermejo et al., 2012; Gottipati & Helleday, 2009). To test involvement of Bye1 in
R-loop formation, we over-expressed RNase H1 (RNH1) in mutants described above. RNH1
speciﬁcally cleaves RNA strands in DNA:RNA duplexes (Crouch et al., 2001), and therefore
rescues growth defects resulting from impaired resolving of R-loops.
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Figure 23: Sensitivity of mutants to DNA damaging agents.
Serial dilutions of strains bye1∆, fyv6∆, bye1∆ fyv6∆, tho2∆, bye1∆ tho2∆, paf1∆, bye1∆ paf1∆ , and an isogenic wild-type
(WT) control strain were placed on YPD and YPD containing indicated amounts of (A) HU, (B) Phleomycin, (C) Etoposide and
(D) MMS, and were incubated at 30 ◦C for 3 days.
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Table 17: Sensitivity of mutants to DNA damaging agents (Summary of Fig. 23).
Growth of WT and mutant cells on media containing diﬀerent DNA damaging agents is indicated, ranging from normal growth
(+++) to no growth/letahlity (-). Parentheses indicate intermediate values.
yeast strain YPD HU Phleomycin Etoposide MMS
WT +++ +(+) ++ ++ +(+)
bye14 +++ +(+) ++ ++ +(+)
fyv64 ++ - + + (+)
bye14fyv64 + (+) (+) + (+)
tho24 ++(+) + ++ ++ +(+)
bye14tho24 ++ (+) + + (+)
paf14 ++(+) + ++ ++ (+)
bye14paf14 + - - + -
As shown in Fig. 24, RNH1 over-expression did not have an eﬀect on growth defects ob-
served before, indicating that tested mutants are not defective in resolving R-loops. To further
test whether phenotypes observed in 9.3 result rather from defects in cell cycle progression
in general, ﬂuorescence-activated cell sorting (FACS) was carried out as described in 7.2.15.
Except for fyv6∆ and bye1∆fyv6∆ mutants, all mutants showed normal cell cycle progression
and DNA content (Fig. 25A). fyv6∆ mutants showed a strong defect in cell cycle progression
and aneuploidy (Fig. 25B), and this defect was partially reduced in bye1∆fyv6∆ mutants (Fig.
25C).
Figure 24: RNase H1 over-expression in mutant yeast cells.
Serial dilutions of strains bye14, paf14, bye14paf14, tho24, bye14tho24, fyv64, bye14fyv64 and an isogenic wild-type
(WT) control strain harbouring a plasmid for Gal-induced RNase H1 over-expression were placed on YPD and YP-Gal. Plates
were incubated at 30°C for 3 days, and RNase H1 over-expression was conﬁrmed by Westernblotting against HA-tagged RNase
H1.
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Figure 25: fyv6∆ and bye1∆fyv6∆ mutants are aneuploid.
FACS analysis of WT and (A) bye1∆, (B) fyv6∆ and (C) bye1∆fyv6∆ mutants. Cell cycle phases (G1, G2) are indicated.
9.4 Cells over-expressing Bye1 show no growth defects
As depletion of bye1 in S.cerevisiae does not show any obvious phenotypes, we generated
a strain over-expressing Bye1 (described in 7.1.3) and checked for growth defects. Over-
expression was induced by galactose and conﬁrmed by Westernblotting against HA-tagged
Bye1. Strains were placed on YP-Gal plates as well as plates containing 6-AU to check for
transcription-related growth defects. As can be seen in Fig. 26, cells over-expressing bye1 did
not show any growth defects or altered sensitivity to 6-AU.
Figure 26: Cells over-expressing bye1 show no growth defects.
Serial dilutions of wild-type (WT) control strain and a strain harbouring a genomically inserted Gal-promoter upstream of the
Bye1 ORF (pGAL Bye1). Cells were placed on YP-Gal and plates containing 200 µg/ml 6-AU and incubated at 30°C for 3 days.
Bye1 over-expression was conﬁrmed by WB against HA-tagged Bye1.
9.5 Bye1 and TFIIS compete for Pol II-binding
As the structure of Bye1-bound Pol II revealed binding of Bye1 to Pol II at the same position
as TFIIS (see Fig. 10), we wondered whether there is a direct competition for Pol II binding
between Bye1 and TFIIS. To test this, we formed a stable Pol II-Bye1 complex (see 7.2.2)
containing a mismatch scaﬀold (see 6.3). After addition of TFIIS, we monitored TFIIS-induced
RNA cleavage, which indicates Pol II-TFIIS complex formation and therefore Bye1 displacement
from the complex. As can be seen in Fig. 27, TFIIS-induced RNA cleavage could be observed
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in the presence of Bye1, even at a 30X molar excess over Pol II. This indicates that TFIIS can
displace Bye1 in vitro, and that TFIIS aﬃnity to Pol II is higher than that of Bye1. These
ﬁndings ﬁt with a previously published dissociation constant for the Pol II-TFIIS interaction
of 60 nM (Awrey et al. 1998), which is more than 60X stronger than that for the Pol II-Bye1
interaction (8.1).
Figure 27: TFIIS has a higher aﬃnity to Pol II than Bye1.
(A) Nucleic acid scaﬀold for reconstitution of Pol II-nucleic acid complex. (B) Scheme depicting order of addition of components.
(C) Electrophoretic separation of RNA cleavage products.
To further investigate a possible competition, we determined occupancy levels of Bye1
and TFIIS at housekeeping genes in WT cells, and dst1∆ and bye1∆ mutants, respectively.
Occupancy levels for Bye1 and TFIIS were similar in WT cells, and were neither aﬀected
for Bye1 nor TFIIS in mutant backgrounds (Fig. 28A, B), suggesting that Pol II-Bye1 and
Pol II-TFIIS complexes co-exist in cells. As it has been reported that TFIIS sustains Pol II
activity in ribosomal protein (RP) genes under transcriptional stress, and is therefore required
for the balance between rDNA transcripts and RPs mRNAs (Gómez-Herreros et al. 2012), we
determined occupancy levels of Bye1 and TFIIS at a RP gene in WT cells, and dst1∆ and
bye1∆ mutants, respectively. Bye1 occupancy levels were unchanged in a dst1∆ background
compared to WT (Fig. 28C), whereas increased occupancy levels for TFIIS were observed in a
bye1∆ background, compared to WT (Fig. 28D). These results indicate that Bye1 functions
upstream of TFIIS in transcriptional regulation of RP genes, and that the presence of Bye1
limits the number of TFIIS molecules present at these genes.
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Figure 28: TFIIS recruitment to ribosomal protein genes is altered in bye1∆ mutants.
ChIP-analysis reveals that recruitment to housekeeping genes of (A) Bye1 and (B) TFIIS is not aﬀected in dst1∆ and bye1∆
mutants (grey), respectively, compared to WT cells (black). Similarly, recruitment of Bye1 to the ribosomal protein gene RPL3
is not aﬀected in dst1∆ mutants (grey) compared to WT cells (black) (C). In contrast, TFIIS occupancy is increased in bye1∆
mutants (grey) compared to WT cells (black) (D). The fold enrichments at the ADH1, PMA1 and RPL3 gene over a non-
transcribed region that is located near the centromere of chromosome V are given for the 5' UTR, the ORF region and the 3'
UTR. The standard deviations are for two independent ChIP experiments.
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Part IV
Conclusions and outlook
From the work described here, we could show that Bye1 binds to Pol II, and report crystal
structures of the central TLD domain of Bye1 bound to free Pol II, a Pol II elongation complex
with DNA template and RNA transcript, an elongation complex with an NTP analogue, and
an arrested elongation complex with backtracked RNA. These studies represent only the third
high-resolution structural analysis of a transcription factor complex with the polymerase core.
Whereas the previously studied factors TFIIB (Bushnell et al., 2004; Kostrewa et al., 2009; Liu
et al., 2010; Sainsbury et al., 2013) and TFIIS (Kettenberger et al., 2003, 2004; Cheung &
Cramer, 2011; Wind & Reines, 2000; Wang et al., 2009) alter Pol II function by directly aﬀecting
catalytic events, Bye1 does not alter basic Pol II functions in vitro. Consistent with this, Bye1
binding to Pol II does not alter Pol II conformation in the structures. Additional functional
data in vitro and in vivo indicate that Bye1 occupies active genes in their 5'-region and can
bind to histone H3 tails with post-translational modiﬁcations (PTMs) of active transcription
using its PHD domain. A chromatin-related function of Bye1 may explain published genetic
evidence for a negative role of Bye1 in transcription elongation (Wu et al., 2003).
What could be the function of Bye1 in chromatin transcription? One possibility is the
prevention of histone loss during polymerase passage through chromatin. Because the TLD
of Bye1 is required for chromatin association of Bye1, it is unlikely that Bye1 ﬁrst recognizes
active chromatin marks, and then recruits Pol II to active chromatin regions. Instead we
speculate that Bye1 binds directly to Pol II during early transcription elongation and tethers
surrounding histones containing active PTMs. This hypothesis also ﬁts our observations that
Bye1 does not alter Pol II conformation or function, but rather uses Pol II as a binding platform.
Bye1 may cooperate with other chromatin elongation factors such as Spt6 and FACT (Duina,
2011; Winkler & Luger, 2011) to prevent loss of histones during polymerase passage through
chromatin. Therefore, Bye1 might be the founding member of a new family of transcription
factors that tether early transcribing Pol II to histones, thereby possibly preventing deregulated
transcription that may arise from histone loss. Such a mechanism may account for the apparent
function of the human Bye1 homologues PHF3 and DIDO in suppressing cancer development
(Fischer et al., 2001; Fütterer et al., 2005). To strengthen this hypothesis, Bye1 function would
have to be elucidated further in a chromatin background, possibly by extending established
methods of nucleosome localization towards monitoring histone loss in bye1∆ mutants. In
addition, involvement of the human Bye1 homologues in chromatin transcription should be
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analysed to support the hypothesis and to transfer the ﬁndings from yeast to humans.
A second possibility is the involvement of Bye1 in cryptic transcription. Unpublished data
from the Strahl lab showed that over-expression of Bye1 induces transcription from cryptic pro-
moters in a yeast strain harboring a reporter for cryptic transcription, and this was dependent
on the TLD domain. These ﬁndings ﬁt with our Bye1 ChIP data, where increased occupancy
was observed downstream of the polyA site, indicating divergent transcription. Further indica-
tion arises from the genetic link between Bye1 and Ess1, which has been shown to repress the
initiation of cryptic unstable transcripts (CUTs) (Ma et al., 2012). Finally, we showed binding
of Bye1 to trimethylated H3K4, which has been linked to transcription from cryptic promoters
(Pinskaya et al., 2009). To corroborate involvement of Bye1 in cryptic transcription, Bye1
ChIP data has to be analysed in depth in relation to cryptic promoters, and a possible link
between Bye1 and the Nrd1-dependent termination of non-coding RNAs (Schulz, Schwalb et
al., submitted) should be elucidated, as Nrd1 recruitment is dependent on H3K4me3 and Set1
(Terzi et al., 2011).
Finally, a function of Bye1 in transcription of ribosomal protein (RP) genes could be in-
vestigated further. ChIP-occupancies of Bye1 and TFIIS on the RP gene Rpl3 suggested that
Bye1 functions upstream and counteracts recruitment of TFIIS, as TFIIS occupancy levels are
increasing upon depletion of Bye1. As a role for TFIIS in sustaining Pol II levels on RP genes
under transcriptional stress has been described (Gómez-Herreros et al., 2012), occupancy levels
of Bye1 and TFIIS on all RP genes, and in mutant backgrounds, should be investigated under
transcriptional stress.
In addition, characterization of the SPOC domain should be a major focus to further
elucidate Bye1 function. The function of SPOC domains in yeast is unclear, but in higher
eukaryotes SPOC domains are implicated in developmental signalling (Ariyoshi & Schwabe,
2003), and are involved in protein-protein interactions (Hiriart et al., 2005; Debeauchamp
et al., 2008). Therefore, an interaction screen should be carried out in order to identify possible
interacting partners of the SPOC domain. This could be done either by using the SPOC domain
as bait in a yeast-two-hybrid screen, or by using a recombinant SPOC domain for pull-down
assays with yeast lysate. Crystallization and structure solution of the SPOC domain may
allow for further structural and possibly even functional characterization. Unpublished data
from our and other labs implied that the human Bye1 homolog, PHF3, interacts with the
C-terminal domain of Rpb1, the largest Pol II subunit, and we believe that the SPOC domain
could be involved in this interaction. Speciﬁcally, PHF3 interacts with Tyrosine1-Serine2-
phosphorylated (Y1PS2P) CTD peptides, and this phosphorylation pattern is present during
productive transcription elongation (Heidemann et al., 2013). An interaction of Bye1 and
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speciﬁcally the SPOC domain with diﬀerentially phosphorylated CTD peptides should therefore
be tested, and if an interaction can be proven, crystallization of a SPOC-CTD complex would
be the logical next step.
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Table 18: List of microarrayed peptides
Peptide Residues Sequence Annotation
P1 H3 1-20 ARTKQTARKSTGGKAPRKQL-K(Biot)-
NH2
H3 (1-20)
P2 H3 1-20 ARTKQTARKSTGGK(Ac)APRKQL-
K(Biot)-NH2
H3K14ac
P3 H3 1-20 ARTKQTARK(Ac)STGGKAPRKQL-
K(Biot)-NH2
H3K9ac
P4 H3 1-20 ARTK(Ac)QTARKSTGGKAPRKQL-
K(Biot)-NH2
H3K4ac
P5 H3 1-20 ARTK(Ac)QTARKSTGGK(Ac)APRKQL-
K(Biot)-NH2
H3K4ac + K14ac
P6 H3 1-20 ARTKQTARK(Ac)STGGK(Ac)APRKQL-
K(Biot)-NH2
H3K9ac + K14ac
P7 H3 1-20 ARTK(Ac)QTARK(Ac)STGGKAPRKQL-
K(Biot)-NH2
H3K4ac + K9ac
P8 H3 1-20 ARTK(Ac)QTARK(Ac)STGGK(Ac)APRK
QL-K(Biot)-NH2
H3K4ac + K9ac + K14ac
P10 H3 1-20 ARTKQTARKSTGGKAPRK(Ac)QL-
K(Biot)-NH2
H3K18ac
P11 H3 1-20 ARTKQTARKSTGGK(Ac)APRK(Ac)QL-
K(Biot)-NH2
H3K14ac + K18ac
P12 H3 1-20 ARTKQTARK(Ac)STGGKAPRK(Ac)QL-
K(Biot)-NH2
H3K9ac + K18ac
P13 H3 1-20 ARTK(Ac)QTARKSTGGKAPRK(Ac)QL-
K(Biot)-NH2
H3K4ac + K18ac
P14 H3 1-20 ARTKQTARK(Ac)STGGK(Ac)APRK(Ac)
QL-K(Biot)-NH2
H3K9ac + K14ac + K18ac
P15 H3 1-20 ARTK(Ac)QTARKSTGGK(Ac)APRK(Ac)
QL-K(Biot)-NH2
H3K4ac + K14ac + K18ac
P16 H3 1-20 ARTK(Ac)QTARK(Ac)STGGKAPRK(Ac)
QL-K(Biot)-NH2
H3K4ac + K9ac + K18ac
P17 H3 1-20 ARTK(Ac)QTARK(Ac)STGGK(Ac)APRK
(Ac)QL-K(Biot)-NH2
H3K4ac + K9ac + K14ac
+ K18ac
P18 H3 1-20 ARTK(Me3)QTARKSTGGKAPRKQL-K
(Biot)-NH2
H3K4me3
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P19 H3 1-20 ARTK(Me3)QTARK(Ac)STGGKAPRKQL-
K(Biot)-NH2
H3K4me3 + K9ac
P20 H3 1-20 ARTK(Me3)QTARKSTGGK(Ac)APRKQL-
K(Biot)-NH2
H3K4me3 + K14ac
P21 H3 1-20 ARTK(Me3)QTARKSTGGKAPRK(Ac)QL-
K(Biot)-NH2
H3K4me3 + K18ac
P22 H3 1-20 ARTK(Me3)QTARK(Ac)STGGK(Ac)APR
KQL-K(Biot)-NH2
H3K4me3 + K9ac +
K14ac
P23 H3 1-20 ARTK(Me3)QTARK(Ac)STGGKAPR
K(Ac)QL-K(Biot)-NH2
H3K4me3 + K9ac +
K18ac
P24 H3 1-20 ARTK(Me3)QTARKSTGGK(Ac)APR
K(Ac)QL-K(Biot)-NH2
H3K4me3 + K14ac +
K18ac
P25 H3 1-20 ARTK(Me3)QTARK(Ac)STGGK(Ac)APR
K(Ac)QL-K(Biot)-NH2
H3K4me3 + K9ac +
K14ac + K18ac
P26 H3 1-20 ARpTK(Me3)QTARK(Ac)STGGK(Ac)AP
RK(Ac)QL-K(Biot)-NH2
H3T3p + K4me3 + K9ac
+ K14ac + K18ac
P27 H3 1-20 ARpTK(Me3)QTARKSTGGKAPRKQL-
K(Biot)-NH2
H3T3p + K4me3
P28 H3 1-20 AR(Me2a)pTK(Me3)QTARK(Ac)STGG
K(Ac)APRK(Ac)QL-K(Biot)-NH2
H3R2me2a + T3p +
K4me3 + K9ac + K14ac
+ K18ac
P29 H3 1-20 AR(Me2a)pTK(Me3)QTARKSTGGKAPR
KQL-K(Biot)-NH2
H3R2me2a + T3p +
K4me3
P30 H3 1-20 AR(Me2a)TK(Me3)QTARKSTGGKAPRK
QL-K(Biot)-NH2
H3R2me2a + K4me3
P32 H3 1-20 ARTK(Me2)QTARKSTGGKAPRKQL-
K(Biot)-NH2
H3K4me2
P33 H3 1-20 ARTK(Me2)QTARK(Ac)STGGK(Ac)APR
K(Ac)QL-K(Biot)-NH2
H3K4me2 + K9ac +
K14ac + K18ac
P34 H3 1-20 ARTK(Me)QTARKSTGGKAPRKQL-
K(Biot)-NH2
H3K4me1
P35 H3 1-20 ARTK(Me)QTARK(Ac)STGGK(Ac)APR
K(Ac)QL-K(Biot)-NH2
H3K4me1 + K9ac +
K14ac + K18ac
P36 H3 1-20 ARTKQTARKpSTGGKAPRKQL-
K(Biot)-NH2
H3S10p
P37 H3 1-20 ARTK(Ac)QTARK(Ac)pSTGGK(Ac)AP
RK(Ac)QL-K(Biot)-NH2
H3K4ac + K9ac + S10p
+ K14ac + K18ac
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P38 H3 1-20 ARTK(Me3)QTARKpSTGGKAPRKQL-
K(Biot)-NH2
H3K4me3 + S10p
P39 H3 1-20 ARTK(Me3)QTARK(Ac)pSTGGK(Ac)AP
RK(Ac)QL-K(Biot)-NH2
H3K4me3 + K9ac + S10p
+ K14ac + K18ac
P40 H3 1-20 AR(Me2a)TK(Me3)QTARKpSTGGKAPR
KQL-K(Biot)-NH2
H3R2me2a + K4me3 +
S10p
P41 H3 1-20 AR(Me2a)TK(Me3)QTARK(Ac)pSTGG
K(Ac)APRK(Ac)QL-K(Biot)-NH2
H3R2me2a + K4me3 +
K9ac + S10p + K14ac +
K18ac
P42 H3 1-20 ARTKQTARK(Me3)STGGKAPRKQL-
K(Biot)-NH2
H3K9me3
P43 H3 1-20 ARTK(Ac)QTARK(Me3)STGGK(Ac)APR
K(Ac)QL-K(Biot)-NH2
H3K4ac + K9me3 +
K14ac + K18ac
P44 H3 1-20 ARTK(Me2)QTARK(Ac)STGGKAPR
K(Ac)QL-K(Biot)-NH2
H3K4me2 + K9ac +
K18ac
P45 H3 1-20 ARTK(Me)QTARK(Ac)STGGKAPR
K(Ac)QL-K(Biot)-NH2
H3K4me1 + K9ac +
K18ac
P47 H3 1-20 AR(Me2a)TKQTARKSTGGKAPRKQL-
K(Biot)-NH2
H3R2me2a
P48 H3 1-20 AR(Me2a)TK(Ac)QTARK(Ac)STGG
K(Ac)APRK(Ac)QL-K(Biot)-NH2
H3R2me2a + K4ac +
K9ac + K14ac + K18ac
P50 H3 1-20 AR(Me2a)TK(Me3)QTARK(Ac)STGG
K(Ac)APRK(Ac)QL-K(Biot)-NH2
H3R2me2a + K4me3 +
K9ac + K14ac + K18ac
P51 H3 1-20 AR(Me)TK(Me3)QTARKSTGGKAPRKQ
L-K(Biot)-NH2
H3R2me1 + K4me3
P52 H3 1-20 AR(Me)TK(Me3)QTARK(Ac)STGGK(Ac)
APRK(Ac)QL-K(Biot)-NH2
H3R2me1 + K4me3 +
K9ac + K14ac + K18ac
P53 H3 1-20 ACitTKQTARKSTGGKAPRKQL-
K(Biot)-NH2
H3Cit2
P54 H3 1-20 ACitTK(Me3)QTARKSTGGKAPRKQL-
K(Biot)-NH2
H3Cit2 + K4me3
P55 H3 1-20 ACitTK(Me3)QTARK(Ac)STGGK(Ac)A
PRK(Ac)QL-K(Biot)-NH2
H3Cit2 + K4me3 + K9ac
+ K14ac + K18ac
P56 H3 1-20 ACitTK(Ac)QTARK(Ac)STGGK(Ac)APR
K(Ac)QL-K(Biot)-NH2
H3Cit2 + K4ac + K9ac +
K14ac + K18ac
P57 H3 1-20 ARpTKQTARKSTGGKAPRKQL-Peg-
K(Biot)-NH2
H3T3p
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P58 H4 1-23 Ac-
SGRGK5GGKGLGKGGAKRHRKVLR-
Peg-Biot
H4 (1-23)
P59 H4 1-23 Ac-SGRGK(Ac)GGK(Ac)GLGK(Ac)GGA
K(Ac)RHRKVLR-Peg-Biot
H4K5ac + K8ac + K12ac
+ K16ac
P60 H3 1-20 AR(Me2a)TK(Me2)QTARKSTGGKAPRK
QL-K(Biot)-NH2
H3R2me2a + K4me2
P61 H3 1-20 AR(Me2s)TK(Me2)QTARKSTGGKAPRK
QL-K(Biot)-NH2
H3R2me2s + K4me2
P62 H3 1-20 AR(Me)TK(Me2)QTARKSTGGKAPRKQL-
K(Biot)-NH2
H3R2me1 + K4me2
P63 H3 1-20 ACitTK(Me2)QTARKSTGGKAPRKQL-
K(Biot)-NH2
H3Cit2 + K4me2
P66 H4 1-23 Ac-SGRGK(Ac)GGKGLGKGGAKRHRK
VLR-Peg-Biot
H4K5ac
P67 H4 1-23 Ac-SGRGKGGK(Ac)GLGKGGAKRHRK
VLR-Peg-Biot
H4K8ac
P68 H4 1-23 Ac-SGRGKGGKGLGK(Ac)GGAKRHRK
VLR-Peg-Biot
H4K12ac
P69 H4 1-23 Ac-SGRGKGGKGLGKGGAK(Ac)RHRK
VLR-Peg-Biot
H4K16ac
P70 H4 1-23 Ac-SGRGK(Ac)GGKGLGK(Ac)GGAKRH
RKVLR-Peg-Biot
H4K5ac + K12ac
P71 H4 1-23 Ac-SGRGKGGK(Ac)GLGKGGAK(Ac)RH
RKVLR-Peg-Biot
H4K8ac + K16ac
P72 H4 1-23 Ac-SGRGK(Ac)GGK(Ac)GLGK(Ac)GGA
KRHRKVLR-Peg-Biot
H4K5ac + K8ac + K12ac
P73 H4 1-23 Ac-SGR(Me2a)GKGGKGLGKGGAKRHR
KVLR-K(Biot)-NH2
H4R3me2a
P74 H4 1-23 Ac-SGR(Me2s)GKGGKGLGKGGAKRHR
KVLR-K(Biot)-NH2
H4R3me2s
P75 H4 1-23 Ac-SGR(Me)GKGGKGLGKGGAKRHRK
VLR-K(Biot)-NH2
H4R3me1
P76 H4 1-23 Ac-pSGR(Me2a)GKGGKGLGKGGAKRH
RKVLR-K(Biot)-NH2
H4S1p + R3me2a
P77 H4 1-23 Ac-pSGR(Me2s)GKGGKGLGKGGAKRH
RKVLR-K(Biot)-NH2
H4S1p + R3me2s
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P78 H4 1-23 Ac-pSGR(Me)GKGGKGLGKGGAKRHR
KVLR-K(Biot)-NH2
H4S1p + R3me1
P79 H4 1-23 Ac-
SGR(Me2a)GK(Ac)GGK(Ac)GLGK(Ac)
GGAK(Ac)RHRK(Ac)VLR-K(Biot)-NH2
H4R3me2a + K5ac +
K8ac + K12ac + K16ac +
K20ac
P80 H4 1-23 Ac-
SGR(Me2s)GK(Ac)GGK(Ac)GLGK(Ac)
GGAK(Ac)RHRK(Ac)VLR-K(Biot)-NH2
H4R3me2s + K5ac +
K8ac + K12ac + K16ac +
K20ac
P81 H4 1-23 Ac-SGR(Me)GK(Ac)GGK(Ac)GLGK(Ac)
GGAK(Ac)RHRK(Ac)VLR-K(Biot)-NH2
H4R3me1 + K5ac + K8ac
+ K12ac + K16ac +
K20ac
P82 H4 11-27 Ac-GKGGAKRHRK(Me3)VLRDNIQ-
Peg-Biot
H4K20me3
P83 H4 11-27 Ac-GKGGAKRHRK(Me2)VLRDNIQ-
Peg-Biot
H4K20me2
P84 H4 11-27 Ac-GKGGAKRHRK(Me)VLRDNIQ-Peg-
Biot
H4K20me1
P85 H4 11-27 Ac-GK(Ac)GGAK(Ac)RHRK(Me3)VLRD
NIQ-Peg-Biot
H4K12ac + K16ac +
K20me3
P86 H4 11-27 Ac-GK(Ac)GGAK(Ac)RHRK(Me2)VLRD
NIQ-Peg-Biot
H4K12ac + K16ac +
K20me2
P89 H3 1-20 ARTK(Me3)QTAR(Me2s)K(Me3)STGGK
APRKQL-K(Biot)-NH2
H3K4me3 + R8me2s +
K9me3
P90 H3 15-43 Ac-APRK18QLATK23AARK27SAPSTG
GVK36K37PHRYGGK(Biot)-NH2
H3 (15-41)
P91 H3 15-43 Ac-APRK(Me3)QLATKAARKSAPSTGG
VKKPHRY-GG-K(Biot)-NH2
H3K18me3
P93 H3 15-43 Ac-APRKQLATKAARKSAPSTGGV
K(Me3)KPHRY-GG-K(Biot)-NH2
H3K36me3
P95 H3 15-43 Ac-APRK(Me3)QLATKAARKSAPSTGG
VK(Me3)KPHRY-GG-K(Biot)-NH2
H3K18me3 + K36me3
P96 H3 1-20 ARTK(Me3)QTAR(Me2a)K(Me3)STGGK
APRKQL-K(Biot)-NH2
H3K4me3 + R8me2a +
K9me3
P99 H4 11-27 Ac-GKGGAKRHRKVLRDNIQ-Peg-Biot H4 (11-27)
P100 H3 74-84 Ac-IAQDFKTDLRF-Peg-K(Biot)-NH2 H3 (74-84) N-ac
P101 H3 74-84 Ac-IAQDFK(Me3)TDLRF-Peg-K(Biot)-
NH2
H3K79me3
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P102 H3 74-84 Ac-IAQDFK(Me2)TDLRF-Peg-K(Biot)-
NH2
H3K79me2
P103 H3 74-84 Ac-IAQDFK(Me)TDLRF-Peg-K(Biot)-
NH2
H3K79me1
P104 H3 74-84 IAQDFKTDLRF-Peg-K(Biot)-NH2 H3 (74-84)
P120 H3 27-45 KSAPSTGGVK(Me3)KPHRYKPGT-G-
K(Biot)-NH2
H3K36me3 (27-45)
P121 H3 27-45 KSAPSTGGVK(Me2)KPHRYKPGT-
GG-K(Biot)-NH2
H3K36me2 (27-45)
P123 H3 27-45 KSAPSTGGVK(Ac)KPHRYKPGT-GG-
K(Biot)-NH2
H3K36ac (27-45)
P124 H3 27-45 KSAPSTGGVKKPHRYKPGT-GG-
K(Biot)-NH2
H3 (27-45)
P125 H3 1-20 ARpTKQTARKSTGGKAPRKQL-
K(Biot)-NH2
H3T3p
P129 H3 6-30 Ac-TARK(Me2)STGGKAPRKQLATKA
ARK(Me2)SAP-Peg-K(Biot)-NH2
H3K9me2 + K27me2
P132 H3 1-20 ARTK(Me3)QTARK(Me3)STGGKAPRK
QL-K(Biot)-NH2
H3K4me3 + K9me3
P133 H3 1-20 ARTKQTARK(Me2)STGGKAPRKQL-
K(Biot)-NH2
H3K9me2
P134 H3 1-20 ARTKQTARK(Me)STGGKAPRKQL-
K(Biot)-NH2
H3K9me1
P137 H3 1-20 ARTKQTARKSTGGKAPRK(Me3)QL-
K(Biot)-NH2
H3K18me3
P138 H3 1-20 ARTKQTARKSTGGKAPRK(Me2)QL-
K(Biot)-NH2
H3K18me2
P139 H3 1-20 ARTKQTARKSTGGKAPRK(Me)QL-
K(Biot)-NH2
H3K18me1
P144 H3 1-20 ARTKQTARK(Ac)pSTGGKAPRKQL-
K(Biot)-NH2
H3K9ac + S10p
P145 H3 1-20 ARTKQTARK(Me3)pSTGGKAPRKQL-
K(Biot)-NH2
H3K9me3 + S10p
P146 H3 1-20 ARTKQTARK(Me2)pSTGGKAPRKQL-
K(Biot)-NH2
H3K9me2 + S10p
P147 H3 1-20 ARTKQTARK(Me)pSTGGKAPRKQL-
K(Biot)-NH2
H3K9me1 + S10p
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P148 H3 1-20 ARTK(Me3)QTARK(Ac)pSTGGKAPRK
QL-K(Biot)-NH2
H3K4me3 + K9ac + S10p
P149 H3 1-22 ARTKQTARKSTGGKAPR(Me2a)KQLA
T-K(Biot)-NH2
H3R17me2a
P150 H3 1-22 ARTKQTARKSTGGKAPR(Me2s)KQLA
T-K(Biot)-NH2
H3R17me2s
P151 H3 1-22 ARTKQTARKSTGGKAPR(Me)KQLAT-
K(Biot)-NH2
H3R17me1
P157 H3 1-20 AR(Me2s)TK(Me3)QTARKSTGGKAPR
KQL-K(Biot)-NH2
H3R2me2s + K4me3
P162 H3 1-20 ARTKQpTARKSTGGKAPRKQL-
K(Biot)-NH2
H3T6p
P163 H3 1-20 ARTK(Me3)QpTARKSTGGKAPRKQL-
K(Biot)-NH2
H3K4me3 + T6p
P164 H3 1-20 ARTK(Me2)QpTARKSTGGKAPRKQL-
K(Biot)-NH2
H3K4me2 + T6p
P165 H3 1-20 ARTKQpTARK(Ac)STGGK(Ac)APR
K(Ac)QL-K(Biot)-NH2
H3T6p + K9ac + K14ac
+ K18ac
P166 H3 1-20 ARTK(Me3)QpTARK(Ac)STGGK(Ac)AP
RK(Ac)QL-K(Biot)-NH2
H3K4me3 + T6p + K9ac
+ K14ac + K18ac
P167 H3 1-20 ARTK(Me2)QpTARK(Ac)STGGK(Ac)AP
RK(Ac)QL-K(Biot)-NH2
H3K4me2 + T6p + K9ac
+ K14ac + K18ac
P174 H3 1-20 AR(Me2s)TK(Me3)QTARK(Ac)STGG
K(Ac)APRK(Ac)QL-K(Biot)-NH2
H3R2me2s + K4me3 +
K9ac + K14ac + K18ac
P178 H3 1-20 ARTKQTAR(Me)K(Me3)STGGKAPRK
QL-K(Biot)-NH2
H3R8me1 + K9me3
P179 H3 1-20 ARTKQTAR(Me)K(Me2)STGGKAPRK
QL-K(Biot)-NH2
H3R8me1 + K9me2
P180 H3 1-20 ARTKQTAR(Me2a)K(Me3)STGGKAPR
KQL-K(Biot)-NH2
H3R8me2a + K9me3
P181 H3 1-20 ARTKQTAR(Me2a)K(Me2)STGGKAPR
KQL-K(Biot)-NH2
H3R8me2a + K9me2
P182 H3 1-20 ARTKQTAR(Me2a)K(Me)STGGKAPRK
QL-K(Biot)-NH2
H3R8me2a + K9me1
P183 H3 1-20 ARTKQTAR(Me2s)K(Me3)STGGKAPRK
QL-K(Biot)-NH2
H3R8me2s + K9me3
P184 H3 1-20 ARTKQTAR(Me2s)K(Me2)STGGKAPRK
QL-K(Biot)-NH2
H3R8me2s + K9me2
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P185 H3 1-20 ARTKQTAR(Me2s)K(Me)STGGKAPRK
QL-K(Biot)-NH2
H3R8me2s + K9me1
P186 H3 1-20 ARTK(Ac)QTARK(Me2)STGGK(Ac)APR
K(Ac)QL-K(Biot)-NH2
H3K4ac + K9me2 +
K14ac + K18ac
P187 H3 1-20 ARTK(Ac)QTARK(Me)STGGK(Ac)APR
K(Ac)QL-K(Biot)-NH2
H3K4ac + K9me1 +
K14ac + K18ac
P195 H3 15-34 Ac-APRKQLATKAARK(Me3)SAPSTG
G-Peg-Biot
H3K27me3
P196 H3 15-34 Ac-APRKQLATKAARK(Me2)SAPSTG
G-Peg-Biot
H3K27me2
P197 H3 15-34 Ac-APRKQLATKAARK(Me)SAPSTG
GPeg-Biot
H3K27me1
P198 H3 15-34 Ac-APRKQLATKAAR(Me2a)K(Me3)S
APSTGGPeg-Biot
H3R26me2a + K27me3
P200 H3 15-34 Ac-APRKQLATKAARR(Me2a)K(Me)S
APSTGG-Peg-Biot
H3R26me2a + K27me1
P220 H3 1-20 ARTKQpTARK(Me3)STGGKAPRKQL-
K(Biot)-NH2
H3T6p + K9me3
P221 H3 1-20 ARTKQpTAR(Me2a)K(Me3)STGGKA
PRKQL-K(Biot)-NH2
H3T6p + R8me2a +
K9me3
P224 H3 15-34 Ac-APRKQLATKAAR(Me2a)KSAPST
GG-Peg-Biot
H3R26me2a
P225 H3 15-34 Ac-APRKQLATKAARK(Me3)pSAPST
GG-Peg-Biot
H3K27me3 + S28p
P226 H3 15-34 Ac-APRKQLATKAARK(Me2)pSAPST
GG-Peg-Biot
H3S27me2 + S28p
P229 H3 1-20 ARTK(Ac)QTARK(Me3)STGGKAPRK
QL-K(Biot)-NH2
H3K4ac + K9me3
P237 H3 1-32 ARTKQTARK(Me2)STGGKAPRKQLA
TKAARKSAPAT-Peg-Biot
H3K9me2 (1-32)
P241 H3 15-34 Ac-APRKQLATKAARK(Ac)SAPSTGG-
Peg-Biot
H3K27ac
P242 H3 15-34 Ac-
APRKQLATKAARK(Ac)pSAPSTGG-
Peg-K(Biot)-NH2
H3K27ac + S28p
P243 H3 15-34 Ac-APRKQLATKAARKpSAPSTGG-
Peg-K(Biot)-NH2
H3S28p
P253 H3 52-61 Ac-RRYQKSTELL-Peg-Biot H3 (52-61)
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P254 H3 52-61 Ac-RRYQK(Ac)STELL-Peg-Biot H3K56ac (52-61)
P255 H3 52-61 Ac-RRYQK(Me3)STELL-Peg-Biot H3K56me3 (52-61)
P259 H3 1-15 ARTK(Me2)QTARK(Me2)STGGKA-
Peg-Biot
H3K4me2 + K9me2
P260 H3 1-15 ARTK(Me)QTARK(Me2)STGGKA-Peg-
Biot
H3K4me1 + K9me2
P264 H3 1-15 ARTK(Me3)QTARK(Me2)STGGKA-
Peg-Biot
H3K4me3 + K9me2
P300 H2A 1-17 Ac-SGRGKQGGKARAKAKTR-Peg-Biot H2A (1-17)
P301 H2A 1-17 Ac-SGRGK(Ac)QGGK(Ac)ARAK(Ac)A
K(Ac)TR-Peg-Biot
H2AK5ac + K9ac +
K13ac + K15ac
P302 H2A 1-17 Ac-SGRGK(Ac)QGGKARAKAKTR-Peg-
Biot
H2AK5ac
P303 H2A 1-17 Ac-pSGRGK(Ac)QGGKARAKAKTR-
Peg-Biot
H2AS1p + K5ac
P304 H2A 1-17 Ac-SGR(Me2a)GK(Ac)QGGKARAKAK
TR-Peg-Biot
H2AR3me2a + K5ac
P305 H2A 1-17 Ac-pSGR(Me2a)GK(Ac)QGGKARAKA
KTR-Peg-Biot
H2AS1p + R3me2a +
K5ac
P306 H2A 1-17 Ac-SGCitGK(Ac)QGGKARAKAKTR-
Peg-Biot
H2ACit3 + K5ac
P307 H2A 1-17 Ac-pSGCitGK(Ac)QGGKARAKAKTR-
Peg-Biot
H2AS1p + Cit3 + K5ac
P308 H2A 1-17 Ac-pSGRGK(Ac)QGGK(Ac)ARAK(Ac)
AK(Ac)TR-Peg-Biot
H2AS1p + K5ac + K9ac
+ K13ac + K15ac
P309 H2A 1-17 SGRGK(Ac)QGGK(Ac)ARAK(Ac)A
K(Ac)TR-Peg-Biot
H2AK5ac + K9ac +
K13ac + K15ac (no N-ac)
P310 H2A 1-17 pSGRGK(Ac)QGGK(Ac)ARAK(Ac)A
K(Ac)TR-Peg-Biot
H2AS1p + K5ac + K9ac
+ K13ac + K15ac (no
N-ac)
P311 H2A.X Biot-Peg-G132KKATQAS139QEY142-
OH
H2AX (132-142)
P312 H2A.X Biot-Peg-G132KKATQApS139QEY142-
OH
H2AX (S139p)
P350 H4 1-23 Ac-SGR(Me2a)GK(Ac)GGKGLGKGGAK
RHRKVLR-K(Biot)-NH2
H4R3me2a + K5ac
P351 H4 1-23 SGRGKGGKGLGKGGAKRHRKVLR-
Peg-Biot
H4 (1-23) (no N-ac)
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P352 H4 1-23 Ac-SGRGKGGKGLGKGGAKRHRK(Ac)
VLRD-Peg-Biot
H4K20ac
P353 H4 1-23 Ac-pSGRGK(Ac)GGK(Ac)GLGK(Ac)GG
AK(Ac)RHRKVLR-Peg-Biot
H4S1p + K5ac + K8ac +
K12ac + K16ac
P359 H4 1-23 Ac-SGRGK(Ac)GGK(Ac)GLGKGGAKR
HRKVLR-Peg-Biot
H4K5ac + K8ac
P360 H4 1-23 Ac-SGRGK(Ac)GGKGLGKGGAK(Ac)R
HRKVLR-Peg-Biot
H4K5ac + K16ac
P362 H4 1-23 Ac-SGRGKGGK(Ac)GLGK(Ac)GGAKR
HRKVLR-Peg-Biot
H4K8ac + K12ac
P363 H4 1-23 Ac-SGRGKGGK(Ac)GLGKGGAKRHR
K(Ac)VLR-Peg-Biot
H4K12ac + K16ac
P366 H4 1-23 Ac-SGRGKGGKGLGKGGAK(Ac)RHR
K(Ac)VLR-Peg-Biot
H4K16ac + K20ac
P370 H4 1-23 Ac-
SGRGQGGQGLGK(Ac)GGAQRHRQVLR-
Peg-Biot
H4K12ac + KQ5,8,16,20
P371 H4 1-23 Ac-
SGRGK(Me)GGKGLGKGGAKRHRKVLR-
Peg-Biot
H4K5me1
P372 H4 1-23 Ac-
SGRGKGGK(Me)GLGKGGAKRHRKVLR-
Peg-Biot
H4K8me1
P373 H4 1-23 Ac-
SGRGKGGKGLGK(Me)GGAKRHRKVLR-
Peg-Biot
H4K12me1
P374 H4 1-23 Ac-
SGRGK(Ac)GGK(Me)GLGK(Ac)GGAK
RHRKVLR-Peg-Biot
H4K5ac + K8me1 +
K12ac
P375 H4 1-23 Ac-
SGRGK(Me)GGK(Ac)GLGK(Me)GGAK
RHRKVLR-Peg-Biot
H4K5me1 + K8ac +
K12me1
P376 H4 1-23 Ac-
SGRGK(Me)GGK(Me)GLGK(Me)GGAK
RHRKVLR-Peg-Biot
H4K5me1 + K8me1 +
K12me1
P381 H4 1-23 Ac-SGRGK(Me)GGK(Ac)GLGK(Ac)GGA
K(Ac)RHRKVLR-Peg-Biot
H4K5me1 + K8ac +
K12ac + K16ac
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P382 H4 1-23 Ac-SGRGK(Ac)GGK(Me)GLGK(Ac)GGA
K(Ac)RHRKVLR-Peg-Biot
H4K5ac + K8me1 +
K12ac + K16ac
P383 H4 1-23 Ac-SGRGK(Ac)GGK(Ac)GLGK(Me)GGA
K(Ac)RHRKVLR-Peg-Biot
H4K5ac + K8ac +
K12me1 + K16ac
P400 H2B 1-24 PEPAKSAPAPKKGSKKAVTKAQKK-
Peg-Biot
H2B (1-24)
P401 H2B 1-24 PEPAK(Me3)SAPAPKKGSKKAVTKAQ
KK-Peg-Biot
H2BK5me3
P402 H2B 1-24 PEPAK(Me2)SAPAPKKGSKKAVTKAQ
KK-Peg-Biot
H2BK5me2
P403 H2B 1-24 PEPAK(Me)SAPAPKKGSKKAVTKAQ
KK-Peg-Biot
H2BK5me1
P625 H2A.X Ac-SGRGKTGGKARAKAKSR-Peg-
Biotin
H2A.X (1-17)
P626 H2A.X Ac-SGRGK(Ac)TGGKARAKAKSR-Peg-
Biotin
H2A.X K5ac
P789 H3 27-46 KSAPSTGGVK(Me3)KPHRYRPGTV-
K(biotin)-NH2
H3K36me3
P790 H3 27-46 KSAPpSTGGVK(Me3)KPHRYRPGTV-
K(biotin)-NH2
H3S31p + K36me3
tags
Flag-Tag Biot-Peg-DYKDDDDK-NH2 Flag-Tag
HA-Tag Biot-Peg-YPYDVPDYASL-NH2 HA-Tag
His-Tag Biot-Peg-HHHHHH-NH2 His-Tag
Myc-Tag Biot-Peg-EQKLISEEDL-NH2 Myc-Tag
V5-Tag Biot-Peg-GKPIPNPLLGLDST-NH2 V5-Tag
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nt nucleotide
NTP nucleoside triphosphate
OD600 optical density at 600 nm
ON over night
ORF open reading frame
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PEG poly(ethylene glycol)
PHD plant homeo domain
Phe Phenylalanine
PI protease inhibitor
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Pol DNA-dependent RNA polymerase
PTM post-translational modiﬁcation
qPCR quantitaive PCR
rev reverse
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SL synthetic lethality
SLS Swiss Light Source
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TAE Tris-acetate-EDTA
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TBE tris borate EDTA buﬀer
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TSS transcription start site
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